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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these 
recommendations along with other considerations such as feasibility and 
means of implementation in developing regulatory standards.
It is intended to present successive reports as research and 
epidemiologic studies are completed and as sampling and analytical methods 
are developed. Criteria and standards will be reviewed periodically to 
ensure continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
phenol by members of my staff and the valuable, constructive comments by 
the Review Consultants on Phenol, by the ad hoc committees of the American 
Conference of Governmental Industrial Hygienists and the American Academy 
of Occupational Medicine, and by Robert B. O'Connor, M.D., NIOSH consultant 
in occupational medicine. The NIOSH recommendations for standards are not 
necessarily a consensus of all the consultants and professional societies
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that reviewed this criteria document on phenol. Lists of the NIOSH Review 
Committee members and of the Review Consultants appear on the following
pages.
tÎSJL.m
John F. Finklea, M.D.
Director, National Institute for 
Occupational Safety and Health
The Division of Criteria Documentation and Standards 
Development, National Institute for Occupational 
Safety and Health, had primary responsibility for 
development of the criteria and recommended standard 
for phenol. The Division review staff for this 
document consisted of Richard A. Rhoden, Ph.D., 
Chairman, Howard L. McMartin, M.D., and Barry G. 
King, Ph.D. (consultant). The Department of 
Environmental and Industrial Health, School of 
Public Health, University of Michigan, developed the 
basic information for consideration by NIOSH staff 
and consultants under contract No. HSM-99-73-31. 
Earl S. Flowers, Ph.D., had NIOSH program 
responsibility and served as criteria manager.
v
REVIEW COMMITTEE 
NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH
John F. Bester, Ph.D.
Safety and Occupational Health Study Section 
Herbert J. Brass, Ph.D.
Division of Physical Sciences and Engineering 
Paul E . Caplan
Division of Technical Services 
Larry K. Lowry, Ph.D.
Division of Biomedical and Behavioral Science
James B. Lucas, M.D.
Assistant to the Associate Director 
for Medical Affairs 
Cincinnati Operations
Department of Labor Liaison:
William V. Warren
Division of Health Standards Development 
Occupational Safety and Health Administration
NIOSH REVIEW CONSULTANTS ON PHENOL
Harold V. Brown, Dr. P.H.
Office of Environmental Health and 
Safety, Center for Health Science 
University of California 
Los Angeles, California 90024
Evan E . Campbell 
University of California 
Los Alamos Scientific Laboratory 
Health Group
Los Alamos, New Mexico 87544
Dennis Chamot, Ph.D.
Council of AFL-CIO Unions for 
Professional Employees 
Washington, D.C. 20006
Ralph R. Langner, Ph.D.
Dow Chemical, USA 
Midland, Michigan 43640
Ted A. Loomis, M.D., Ph.D.
School of Medicine 
University of Washington 
Seattle, Washington 98195
John C. Lumsden
North Carolina State Board of Health 
Raleigh, North Carolina 27602
Thomas R. Madden 
Reichhold Chemicals, Inc.
White Plains, New York 10602
Raymond R. Suskind, M.D.
Department of Environmental Health 
University of Cincinnati 
School of Medicine 
Cincinnati, Ohio 45267
Steve Wodka
Oil, Chemical, and Atomic Workers, 
International Union 
Washington, D.C. 20006
CRITERIA DOCUMENT: RECOMMENDATIONS FOR AN





NIOSH REVIEW COMMITTEE vi
NIOSH REVIEW CONSULTANTS vii
I. RECOMMENDATIONS FOR A PHENOL STANDARD
Section 1 - Environmental (Workplace Air) 1
Section 2 - Medical 2
Section 3 - Labeling and Posting 3
Section 4 - Personal Protective Equipment and 6
Protective Clothing 
Section 5 - Informing Employees of Hazards from 11
Phenol
Section 6 - Work Practices 12
Section 7 - Sanitation 18
Section 8 - Monitoring and Recordkeeping Requirements 18
II. INTRODUCTION 21
III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure 23
Historical Reports 25
Effects on Humans 29
Animal Toxicity 48
Correlation of Exposure and Effect 64
Carcinogenicity, Teratogenicity, and Mutagenicity 69
IV. ENVIRONMENTAL DATA
Sampling and Analytical Methods 72
Control of Exposure 76
V. DEVELOPMENT OF STANDARD
Basis for Previous Standards 





VI. WORK PRACTICES 88
VII. OCCUPATIONAL RESEARCH PRIORITIES FOR PHENOL 92
VIII. REFERENCES 94
IX. APPENDIX I - Sampling of Phenol in Air 119
X. APPENDIX II - Analytical Method for Phenol in Air 122
XI. APPENDIX III - Material Safety Data Sheet 129
XII. TABLES AND FIGURES 139
x
I. RECOMMENDATIONS FOR A PHENOL STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to phenol in the workplace be controlled 
by compliance with the following sections. The standard is designed to 
protect the health and to provide for the safety of employees for up to a 
10-hour workday, 40-hour workweek, over a working lifetime. Compliance 
with the standard should prevent adverse effects produced by exposure of 
employees to phenol. The standard is measurable by techniques that are 
valid, reproducible, and available. Sufficient technology exists to permit 
compliance with the recommended standard. The standard will be subject to 
review and revision as necessary.
These criteria and the recommended standard apply to exposure of 
employees to the aromatic organic compound C6H50H, hereinafter referred to 
as phenol. "Phenol" in this recommended standard includes solids, 
aerosols, vapor, or solutions containing phenol.
"Occupational exposure to phenol" is defined as exposure to phenol at 
airborne concentrations exceeding one-^half the recommended TWA 
environmental limit. Exposure at lower concentrations shall not require 
adherence to the following sections except for sections 3, 4(a), 4(b), 5,
and 6.
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to phenol shall be controlled so that no 
employee is exposed to phenol at concentrations greater than 20 mg/cu m in
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air determined as a time-weighted average (TWA) concentration for up to a 
10-hour workday, 40-hour workweek, or to more than 60 mg phenol [ c m  ® air 
as a ceiling concentration for any 15 minute period.
(b) Sampling and Analysis
Procedures for calibration of equipment, sampling, and analysis of
phenol samples shall be as provided in Appendices I and II, or by any 
method shown to be equivalent in precision, accuracy, and sensitivity to 
the methods specified.
Section 2 - Medical
Medical surveillance shall be made available as specified below to 
all employees occupationally exposed to phenol, except that first-aid 
services shall be provided to any employee who is exposed to phenol by 
spills, splashes, or other means of skin or eye contact.
Ca) Preplacement and periodic medical examinations shall be made 
available and shall include:
(1) A comprehensive initial or interim work history.
(2) A medical history which shall cover at least any
history of preexisting disorders of the skin, respiratory tract, liver, and 
kidneys.
(3) A physical examination of at least the cardiovascular
system, respiratory tract, liver, kidneys, and skin. Routine blood tests 
and urine examination and such other biologic tests which are considered 
necessary by the responsible physician may also be included.
(4) An evaluation of the employee's ability to use negative
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or positive pressure respirators.
(5) An initial medical examination shall be made available 
within six months of the promulgation of a standard incorporating these 
recommendations.
(6) Periodic medical surveillance should be made available 
at an interval to be determined by the responsible physician for all 
employees occupationally exposed to phenol.
(b) Appropriate medical services and surveillance shall be 
provided to any employee with adverse health effects reasonably assumed or 
known to be due to exposure to phenol.
Cc) Pertinent medical records shall be maintained for all 
employees occupationally exposed to phenol, and such records shall be kept 
for at least one year after the termination of employment.
(d) These records shall be available to the designated medical 
representatives of the Secretary of Health, Education, and Welfare, of the 
Secretary of Labor, of the employee or former employee, and of the 
employer.
Section 3 - Labeling and Posting
(a) All containers of phenol with capacity in excess of one kilogram 
and contents at a concentration of 1% phenol or greater shall bear the 
following label in addition to, or in combination with, label information 
required by other statutes, regulations, or ordinances:





(% Phenol by weight)
May be fatal if absorbed through skin, inhaled, or swallowed.
Rapidly absorbed through skin.
Causes severe burns of eyes and skin.
Do not breathe vapor or aerosol.
Do not get in eyes, on skin, or on clothing.
Do not take internally.
Wear goggles, face shield, gloves, and protective clothing 
when handling.
FIRST AID CALL A PHYSICIAN AS SOON AS POSSIBLE
In case of contact, immediately flush eyes or skin with 
plenty of water for at least 15 minutes while removing 
contaminated clothing and shoes. Wash clothing before 
reuse.
If inhaled, remove victim to fresh air. Keep warm and quiet. If 
breathing stops, give artificial respiration.
If swallowed, induce vomiting.
(b) In an area where phenol is used or handled, except in enclosed 
systems and for systems in which the concentration of phenol is equal to or 
less than 1%, the following sign shall be posted in readily visible 
locations at or near all entrances to the area and on or near equipment 
using or containing phenol:
d a n g e r !
PHENOL EXPOSURE AREA 
Contact with phenol may be fatal.
Avoid any contact with skin or eyes.
Avoid breathing vapor or aerosol.
(c) In any area where there is bulk storage (greater than 55 
gallons) of phenol or where phenol is used in a manner presenting the 
potential or likelihood of overheating or igniting the phenol, the
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following shall be added to the sign specified in Section 3(b):
Combustible Substance: Releases severely
injurious vapor on overheating or burning.
(d) If respirators are required for protection from phenol, the
following statement shall be added in large letters to the sign required in 
Section 3(b):
RESPIRATORY AND SKIN PROTECTION REOUIFED IN THIS AREA
(e) In any workroom or area where there is likelihood of emergency 
situations arising from accidental skin, eye, or other excessive exposures 
to phenol and where signs are required by Section 3(b), they shall be 
supplemented by additional signs giving: emergency and first-aid
instructions and procedures, the location of first-aid supplies and 
emergency equipment, including respiratory protective equipment, and 
locations of emergency showers and eyewash fountains.
(f) Signs shall be printed in English and in the predominant
language of non-English-reading employees, if any, unless employers use 
equally effective means to ensure that non-English-reading employees know 
the hazards associated with phenol and the areas in which there is
occupational exposure to phenol. Employers shall ensure that illiterate 
employees also know these hazards and the locations of these areas.
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Section 4 - Personal Protective Equipment and Protective Clothing
Engineering controls and safe work practices shall be used to 
maintain exposure to airborne phenol at or below 20 mg/cu m, and protective 
clothing impervious to phenol shall be provided to prevent contact of 
phenol with the body surface. In addition, employers shall provide 
protective equipment and clothing to employees when airborne phenol exceeds 
20 mg/cu m phenol in air. Emergency equipment shall be located at well- 
marked and identified stations and shall be adequate to the needs of all 
personnel to escape from the area or to safely cope with the emergency on 
reentry.
(a) Eye and Face Protection
(1) Cup-type or rubber-framed chemical safety goggles shall 
be worn by employees engaged in activities where it is likely that phenol 
may come in contact with the eye. With airborne phenol at concentrations 
in excess of 20 mg/cu m, a full-face mask respiratory protective device is 
required which will also provide adequate eye protection.
(2) Full-length, plastic face shields shall be worn in 
addition to safety goggles for face protection when working at tasks where 
contact with phenol is likely.
(3) Eye protection measures and equipment shall conform 
with the provisions of ANSI Z87.1-1968.
(b) Protective Clothing
(1) Employers shall provide and employees shall be required
to wear gloves of neoprene, polyethylene, rubber, or other material 
impervious to phenol when working with phenol.
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(2) Employers shall provide and employees shall be required 
to wear protective sleeves, aprons, jackets, trousers, caps, and shoes when 
needed for protection from skin contact with phenol. These garments shall 
be made of a material impervious to phenol.
(3) In emergencies or other circumstances involving
exposure to airborne phenol at concentrations in excess of 20 mg/cu m, full 
body protective clothing shall be worn in addition to a respiratory 
protective device. The garments shall be of an impervious material and
shall fit snugly about the wrists, neck, waist, and ankles.
(4) Employees handling drums, cans, or other containers of 
phenol shall wear impervious shoes or boots with safety toe-caps. Leather 
safety shoes shall be protected from splashes or spills by use of 
impervious coverings such as rubbers.
(5) In unusual, nonroutine, or emergency circumstances 
which may involve occasional periods of exposure to airborne phenol at 
concentrations in excess of 20 mg/cu m, clothing impervious to phenol vapor 
and aerosol shall be supplied by employers and shall be worn to supplement 
the required respiratory protection (see paragraph (c) below) in accordance 
with the requirements in Table 1-1.
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TABLE 1-1
REQUIREMENTS FOR RESPIRATOR USAGE AND SKIN PROTECTION FOR EXPOSURE 
AT CONCENTRATIONS IN EXCESS OF THE ENVIRONMENTAL LIMIT
Phenol
Concentration Respirator Type Impervious Clothing
Less than (1) Chemical cartridge respirator with
60 mg/cu m replaceable organic vapor cartridge
with full facepiece. Maximum ser­
vice life of 3 hours
(2) Full-face gas mask, chin-type, with 
organic vapor canister. Maximum life 
of 4 hours
Required for any 




(1) Chemical cartridge respirator with 
replaceable organic vapor cartridge 
with full facepiece. Maximum ser­
vice life of 3 hours
(2) Full-face gas mask, chin-type, with 
organic vapor canister. Maximum life
of 4 hours
Required for any 






(1) Full-face gas mask, chest- or back- 
mounted type, with industrial size 
organic vapor canister. Maximum 
service life of 2 hours
(2) Type C supplied-air respirator, con- 
tinuous-flow or pressure-demand type 
(positive pressure) with full face­
piece
(1) Self-contained breathing apparatus 
with positive pressure in full face­
piece
(2) Combination supplied-air respirator, 
pressure-demand type, with auxiliary 
self-contained air supply
(3) Type A supplied-air respirator with 
full facepiece and with motor-driven
or hand-operated blower
Required for any 
period of exposure 
over 0.5 hr/day
Required for any 




REQUIREMENTS FOR RESPIRATOR USAGE AND SKIN PROTECTION FOR EXPOSURE 
AT CONCENTRATIONS IN EXCESS OF THE ENVIRONMENTAL LIMIT
Phenol




(1) Self-contained breathing apparatus 
with positive pressure in facepiece
(2) Combination supplied-air respirator 





Firefighting (1) Self-contained breathing apparatus 
with a full facepiece operated in 







(1) Self-contained breathing apparatus 
in demand or pressure-demand mode 
(negative or positive pressure)
(2) Full-face gas mask, front- or back- 





Respirators may be used for nonroutine operations, evacuation, or 
emergencies which may involve occasional brief exposures to phenol at 
concentrations in excess of 20 mg/cu m. Such exposures may occur during
the period necessary to install or test required engineering controls or to
take protective actions.
Appropriate respirators as described in Table 1-1 may only be used 
pursuant to the following requirements:
(1) For the purpose of determining the type of respirator
to be used, the employer shall measure the airborne phenol concentration in 
the workplace, initially and thereafter whenever process, worksite, 
climate, or control changes occur which are likely to increase the airborne 
concentration of phenol. This requirement does not apply when only 
positive pressure supplied-air respirators are used.
(2) The respirator and cartridge or canister used shall be
of the appropriate class, as determined on the basis of the airborne 
concentration of phenol. The employer shall ensure that no employee is
being exposed to phenol in excess of 20 mg/cu m as a TWA concentration
because of improper respirator selection, fit, use, or maintenance.
(3) A respiratory protective program meeting the
requirements of 29 CFR 1910.134 shall be established and enforced by the 
employer.
(4) The employer shall provide respirators in accordance
with Table 1-1 and shall ensure that the employee uses the respirator 
properly.
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(5) Respiratory protective devices described in Table 1-1
shall be those approved under provisions of 30 CFR 11.
(6) Respirators specified for use at greater airborne
concentrations of phenol may be used in lesser airborne concentrations of 
phenol.
(7) Use of chemical cartridges and canisters more than once 
or for a period of time greater than that indicated in Table 1-1 shall be 
prohibited.
(8) The employer shall ensure that respirators are
adequately cleaned, maintained, and stored when not in use, and that 
employees are instructed on the use of respirators assigned to them and on 
how to test for leakage.
Section 5 - Informing Employees of Hazards from Phenol
(a) At the beginning of employment, or assignment for work at
operations, or in an area which may involve overexposure to phenol, each 
employee shall be informed of the hazards of such employment and possible 
injuries due to phenol. He shall be instructed in the proper procedures
for the safe handling and use of this compound, in the operation and use of
protective systems and devices, and in appropriate emergency procedures.
(b) A continuing education program, conducted by a person or
persons qualified by experience or special training, shall be instituted to 
ensure that all employees have current knowledge of job hazards, proper 
maintenance procedures and cleanup methods, and that they know how to use 
respirators correctly. The instructional program shall include a 
description of the general nature of the medical surveillance procedures
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and why it is advantageous to the employee to undergo these examinations. 
As a minimum, instruction shall include the information in Appendix H I ,  
and this information shall also be made available in the work area and kept 
on file, readily accessible to the employee at all places of employment 
where overexposure may occur.
(c) Information shall be recorded on a "Material Safety Data
Sheet" described in Appendix III or on a similar form required or approved 
by the Occupational Safety and Health Administration, US Department of 
Labor.
Section 6 - Work Practices
(a) Appropriate protective clothing and equipment (goggles, face
shields, gloves, aprons, suits, or other personal protective equipment), as 
set forth in Section 4(a), shall be worn by each employee engaged in any 
operation at which there is the likelihood of splashes, spills, or other 
circumstances which may result in phenol coming into contact with the skin 
or eyes of an employee.
(b) Any workplace in which phenol is introduced into the air shall 
be adequately ventilated by either natural or mechanical means sufficient 
to control the airborne concentration of phenol to which any employee may 
be exposed to a value at or below 20 mg/cu m.
(c) Spills and leaks of phenol shall be cleaned up immediately.
Employees engaged in such cleanup operations shall wear suitable protective 
clothing and equipment and respiratory protective devices. The cleanup 
operations shall be done or directly supervised by employees instructed and 
trained in the procedures for the safe decontamination or disposal of
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equipment, materials, and waste. All other persons shall be excluded from 
the area of the spill or leak until cleanup is complete and safe conditions 
have been restored.
(d) Equipment and systems for using, handling, or transferring 
phenol shall be enclosed to the extent that is feasible for the operation 
or shall be otherwise designed or controlled to prevent skin or eye contact 
with, and overexposure to, phenol.
(e) Phenol shall be stored in closed containers in an area which
is adequately ventilated to ensure that airborne phenol concentrations do 
not exceed the limits specified in Section 1(a).
(1) Storage conditions shall be controlled to prevent
overheating and pressure buildup in phenol containers. Transfer and 
storage systems shall be designed and operated to prevent blockage by 
condensed phenol.
(2) When drums of phenol are heated to melt the contents,
the use of open flames is prohibited. Drums shall be placed bung up with 
the bung loosened so that the internal pressure will be vented. Bungs 
shall be tightened prior to moving or handling drums.
(3) Bulk storage facilities shall be designed and 
constructed to contain any leaks or spills.
(4) Storage tanks shall be electrically grounded and bonded
to transfer lines.
(5) Storage containers and transfer lines shall be
maintained in good condition.
(f) Drums, carboys, or other containers of phenol shall be closed
while they are being moved or handled. Transfer from such containers shall
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be done carefully in a manner to prevent splashes, spills, or other 
possible circumstances by which any employee may come into contact with 
phenol,
(1) Leaking containers shall be isolated in adequately 
ventilated areas, or the phenol shall be transferred to an intact 
container. Employees shall wear adequate and appropriate personal and 
respiratory protective equipment during such operations.
(2) Shipping containers to be recycled shall be completely
drained and securely sealed. Phenol shall be cleaned or flushed from the
outside surfaces of the container.
(g) The transfer of phenol to or from tank trucks or cars may be 
done only at facilities designed and designated for such operations. The 
wheels of the tank vehicle shall be chocked, warning signs shall be 
displayed, and barriers shall be erected to prohibit entry of unauthorized
personnel. Connections of the tank and the transfer system shall be
compatible and clearly identified. Only trained, authorized persons may 
carry out the procedures.
(1) No transfer may be made unless authorized by a
responsible supervisor.
(2) Employees authorized to make transfers shall be fully 
trained and familiar with the use of equipment and procedures.
(3) Open flames and smoking shall be prohibited in the area
during transfer operations.
(4) The tank car or truck shall be electrically grounded
and bonded to the transfer line and receiving tank.
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(5) Employees engaged In sampling shall wear respiratory 
and body protection adequate to prevent overexposure.
(6) If leaks or spills occur, they shall be cleaned up
immediately.
(h) Cleaning, maintenance, and repair of tanks, process equipment, 
and lines shall be done only by properly instructed and trained employees 
under responsible supervision. When possible, such work shall be 
accomplished from the outside of the tank or equipment. Entry into 
confined spaces, such as tanks, pits, tank cars, barges, process vessels, 
and tunnels, shall be controlled by a permit system. Permits shall be 
signed by an authorized representative of the employer certifying that 
preparation of the confined space, precautionary measures, and personal 
protective equipment are adequate, and that precautions have been taken to 
ensure that prescribed procedures have been followed.
(1) Before working on tanks, equipment, and lines, proper 
steps shall be followed to protect any employee from overexposure. 
Employees shall avoid contact with phenol-contaminated drainage or 
flushings which shall be drained to a phenol waste system.
(2) If the tank or equipment is to be entered, it shall be 
thoroughly ventilated after being cleaned. The air shall be tested to 
ensure that there is adequate oxygen and that exposure of employees is not 
in excess of 20 mg phenol/cu m in air.
(3) No employee shall enter any tank or equipment which 
does not have an entry large enough to admit an employee equipped with 
safety harness, lifeline, and appropriate respiratory equipment. The 
employee shall be able to leave the tank or vessel by the same opening.
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(4) Employees entering contaminated tanks or equipment
shall wear full body protective clothing until inspection and testing 
provide assurance of safety for personnel in the tank.
(5) An employee shall be stationed at the entry to keep
employees in the tank under constant observation and one or more other 
employees shall be readily available in case of an emergency requiring 
rescue of any employee. An additional supplied-air or self-contained 
breathing apparatus with safety harness and lifeline shall be located
outside the tank or vessel for emergency use.
(6) Provision shall be made for adequate ventilation of the
tank or vessel to provide sufficient breathing air for any employee inside 
and to remove or purge any airborne phenol vapor in excess of 20 mg/cu m. 
The atmosphere in the tank or equipment shall be tested by appropriate 
direct-reading devices to ensure that the oxygen concentration is within 
safe limits.
(7) Before work in or on any tank, line, or equipment
commences, provision shall be made for preventing inadvertent entry of
phenol into the work area.
(8) Exterior work on a tank, vent, or equipment which may
lead to leaking or ignition of phenol is prohibited until the item has been 
cleaned of phenol.
(i) Phenol waste and phenol-contaminated materials shall be 
treated or disposed of by methods which will prevent overexposure.
(j) Emergency showers and eyewash fountains shall be provided and 
maintained at locations readily accessible and close to all areas where 
phenol may contact the skin or eyes.
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(k) Protective clothing, respirators, goggles, and other personal
protective gear which have been contaminated by contact with phenol shall 
be thoroughly washed or cleaned before reuse by any employee. Contaminated 
shoes shall be discarded. Employers shall ensure that all such equipment 
is regularly inspected and maintained and that damaged items are repaired 
or replaced.
(1) Emergency plans and procedures shall be developed and
employees shall be trained to implement the plans effectively.
(1) These procedures shall be reviewed with employees and 
shall be made available in the work areas.
(2) Appropriate emergency equipment including protective 
clothing and emergency and rescue breathing apparatus shall be located in a 
safe area adjacent to places where phenol overexposure could occur.
(3) During emergency situations, all personnel shall be 
evacuated from the area except for the trained and properly equipped 
emergency teams.
(m) The employer shall take the necessary steps to ensure that:
(1) Each employee receives adequate instruction and 
training in safe work practices and emergency procedures, and in the proper 
use of operational equipment and protective devices.
(2) Each employee annually receives refresher sessions and 
drills in safe work practices and emergency procedures.
(3) Each employee is informed of the locations of all 
emergency and first-aid equipment and supplies in the work area.
(4) Each employee is trained in the procedures and informed 
of his responsibility for reporting any emergency, exposure, or injury.
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(5) Each employee is provided personal protective clothing
and necessary safety devices.
(6) Each employee is given adequate, responsible 
supervision to ensure that all safety requirements and practices are 
followed.
(7) Only properly trained and authorized employees are
permitted in areas in which overexposure to phenol is likely.
Section 7 - Sanitation
(a) Eating and food preparation or dispensing (including vending 
machines) shall be prohibited where phenol is present.
(b) Smoking shall be prohibited in areas where phenol is used, 
transfered, stored, or manufactured.
(c) Employees who handle phenol or equipment contaminated with 
phenol shall be instructed to wash their hands thoroughly with soap or mild 
detergent and water before eating or using toilet facilities.
Section 8 - Monitoring and Recordkeeping Requirements
(a) Workplace areas are not considered to have "occupational 
exposure" to phenol if airborne concentrations of phenol as determined on 
the basis of an industrial hygiene survey do not exceed 10 mg/cu m.
Records of these surveys, including the basis for concluding that airborne 
concentrations of phenol do not exceed 10 mg/cu m or 20 mg/cu m as
specified in Section 1(a) shall be maintained.
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(b) Employers shall maintain records of exposure to airborne 
phenol based upon the following sampling and recording schedules:
(1) The first workplace environmental sampling shall be 
completed within six months of the promulgation of a standard incorporating 
these recommendations.
(2) In all monitoring, an adequate number of samples 
representative of the exposure in the breathing zone of the employees shall 
be collected to permit calculation of a TWA concentration exposure for a 
representative group of employees in every work operation involving phenol. 
This shall be performed quarterly for a minimum period of one year until it 
is verified that occupational exposure has not occurred. Thereafter, 
monitoring shall be performed annually unless there are changes in the 
production or process. When this occurs, monitoring shall again be 
conducted to determine each employee's exposure to phenol.
(3) Workplace environmental samples shall be taken within 
30 days after installation of a new process or process changes.
(c) Should environmental sampling indicate airborne phenol 
concentrations between 10 mg/cu m and 20 mg/cu m, samples shall be 
collected in accordance with Appendix I and analyzed in accordance with 
Appendix II, or by equivalent or better methods for determination of the 
airborne phenol concentration.
(d) For work areas in which the phenol concentration exceeds 
20 mg/cu m, corrective measures shall be initiated and monitoring shall be 
repeated on a weekly basis until two consecutive sampling periods have 
shown that airborne phenol concentrations have been reduced to 20 mg/cu m 
or below.
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(e) Records of all sampling and analyses for phenol shall be
maintained for at least one year. Records shall indicate the type of
personal protective devices, if any, in use at the time of sampling. 
Records shall be maintained so that the exposure of each employee can be 
classified or characterized.
(f) Access to records
(1) All records required to be maintained by this section 
shall be made available upon request to authorized representatives of the 
Assistant Secretary of Labor for Occupational Safety and Health or of the 
Director of the National Institute for Occupational Safety and Health.
(2) An employee's exposure determination and exposure 
measurement records required to be maintained by this section shall be made 
available to the employee or his designated representative upon request by 
the employee to the employer.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational 
diseases arising from exposure to phenol. The criteria document fulfills 
the responsibility of the Secretary of Health, Education, and Welfare, 
under Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with the toxic materials and harmful physical 
agents and substances which will describe... exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience...."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect employees from exposure to hazardous chemical and physical agents. 
Criteria for a recommended standard should enable management and labor to 
develop better engineering controls resulting in more healthful work 
environments, and mere compliance with the recommended standard should not 
be regarded as a final goal.
The criteria and recommended standard for phenol are part of a 
continuing series of documents published by NIOSH. The proposed standard 
applies only to the processing, manufacture, and use of phenol as 
applicable under the Occupational Safety and Health Act of 1970. The 
standard was not designed for the population-at-large, and any 
extrapolation beyond the occupational environment is not warranted. It is 
intended to (1) protect against injury from phenol, (2) allow measurement
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by techniques that are valid, reproducible, and available to industry and 
governmental agencies, and (3) be attainable with existing technology.
There is sufficient information to develop a recommended standard for 
phenol, but research on effects produced by prolonged exposure to phenol at 
small concentrations is needed, either by animal studies or by 
epidemiologic investigations. Phenol in excess of normal physiologic 
capacities adversely affects nearly all organs, and an understanding of the 
mechanism of action would be useful in the prevention of adverse effects 
and for the development of a specific medical treatment for intoxication. 
Refinement of sampling and analytical techniques for phenol in workplace 
air would be useful. Well-controlled experiments regarding carcinogenesis, 
mutatgenesis, and teratogenesis are needed.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
The term "phenol" as used in this document refers specifically to 
monohydroxybenzene, C6H50H, [1] which is a clear, colorless, hygroscopic, 
deliquescent, crystalline solid at 25 C. [1,2,3] Impurities may impart a 
light pink color to phenol samples. [1,2,4] Such impurities were not 
considered in the development of the recommended standard. Although 
"phenol" and "phenolics" are terms often used to describe compounds 
containing one or more hydroxyl groups attached to an aromatic ring, [1] it 
is not intended here to develop a standard for compounds other than C6H50H.
The chief chemical and physical properties of phenol are given in 
Table XII-1. Phenol readily forms aqueous solutions and emulsions with the 
amount of phenol actually dissolved in an aqueous solution increasing with 
temperature. [1] In solution, phenol can be oxidized, forming a variety of 
products including benzenediols, benzenetriols, and diphenyls. Reduction 
with removal of the hydroxyl group to form benzene occurs on distillation 
with zinc. [1] Phenol undergoes esterification and can form an ether by 
reactions characteristic of an alcohol. [1] The hydroxyl group is ortho- 
or para-directing in nucleophilic substitution reactions of the aromatic 
ring, [1] and the hydroxyl group participates and is highly reactive in 
condensation reactions with formaldehyde. The aromatic ring can be 
nitrated by nitric acid. [1]
In the US, phenol is produced either synthetically or by the 
fractional distillation of coal tar. [1,5] Synthetic processes are the 
most significant commercially, and production of phenol may be accomplished
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by the following processes: (1) cleavage of cumene hydroperoxide to form
phenol and acetone, (2) the sulfonation of benzene followed by the fusion 
of sodium benzene sulfonate with NaOH to form phenol, (3) hydrolysis of 
chlorobenzene to form phenol in an aqueous sodium hydroxide solution, or
(4) oxidation of toluene to benzoic acid and then to phenol. The 1972 US 
production capacities by process are listed in Table XII-2. Demand for 
phenol in the US was 1,900 million pounds in 1972, and demand has been 
estimated at 2,500 million pounds for 1976. [5]
Phenol is supplied commercially either as a solid or as an aqueous 
solution. [1,2] The USP [6] specification for phenol requires a phenol 
content of not less than 98%, but in practice nearly all synthetic phenol 
has a purity in excess of 99.5%. [1] Commercial grades of phenol obtained 
from distillation of coal tar are either 90-92% phenol or 80-82% phenol, 
the remaining constituents being water and cresol. [1,2] Solid phenol is 
shipped in tank cars, tank trucks, wooden barrels, wooden boxes, aluminum 
drums, nonretumable metal drums, and small containers. [2] Phenol 
solutions are shipped in tank cars, tanks, returnable barrels or drums, 
nonretumable metal drums, boxed glass carboys, and small containers for 
laboratory use. [2]
About 90% of the phenol produced in the US is ultimately used (Table 
XII-3) in the manufacture of phenolic resins, caprolactam, bisphenol-A, 
alkylphenols, and adipic acid. [5,7] A more complete list of uses is found 
in Table XII-4. [8-48] Phenol has also been identified in automobile 
exhaust [49,50] and in cigarette smoke. [49,51]
Occupations in which employees may encounter exposure to phenol are 
listed in Table XII-5. The number of employees who may be exposed to
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phenol has been estimated by NIOSH to be 10,000. This essentially reflects 
that population of employees engaged in commercial production, formulation 
of products, or distribution of concentrated products. A substantial but 
uncertain number of employees indicated by occupation in Table XII-5 may be 
intermittently exposed.
Historical Reports
Historical reports, described below essentially in chronologic order, 
indicate that phenol has long had significant chemical and physical
properties of commercial interests. Phenol has been used in numerous
products and processes, and applications are expected to continue and to
increase. [5] According to Stevens [52] and Wilbert, [53] phenol was 
discovered by Runge who called it "carbon oil acid." Stevens [52] also 
reported that in 1841 Laurent synthesized phenol in pure form and called it 
"hydrate de phenyle," but Gerhardt who prepared phenol from salicylic acid 
later in the mid-nineteenth century was the first to introduce the name 
phenol.
Cook [54] reported that Lemaire was the first to use phenol as a dis­
infectant on wounds. In 1867, Lister [55] reported a new treatment using 
lint soaked in phenol and applied as a covered dressing for compound 
fractures. Tissue was eroded by phenol in all of the 11 cases treated, and 
gas gangrene occurred in 8. One death occurred when the application of 
phenol damaged tissue sufficiently to rupture a femoral artery. There were 
no complaints of pain as a result of the progressive tissue degeneration. 
This was an early report indicating the anesthetic property of phenol.
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Lister [55] also used phenol as a spray for disinfecting operating rooms 
and in solutions for storing catgut sutures.
In 1869, Fuller [56] gave phenol to healthy individuals and to 
patients suffering from a variety of disorders. Oral doses from 0.5 to 1 g 
phenol in 48 ml of an aqueous solution containing 8% glycerol administered 
3 - 4  times/day produced complaints of coldness and a burning sensation in 
the throat upon swallowing. In addition, signs of giddiness, profuse 
perspiration, and a weak pulse were observed in most of the subjects.
Urine collected from those tested was greenish. Some individuals, 
especially those characterized as heavy alcohol drinkers, were able to 
tolerate phenol at similar doses from solutions containing as much as 2%
phenol concentration before these signs were observed or symptoms
developed. Female subjects tolerated only about half the dose tolerated by 
males. Some individuals became faint after inhaling aerosols of phenol 
aspirated directly from 1-2% aqueous phenol, at which time the subjects 
were advised to cease inhalation of the aerosol. Fuller's experiments 
preceded a report of the germicidal action of phenol described by Koch in 
1881. [57]
Many of the effects which have been associated with phenol exposures 
are presented in Table XII-6. In addition to the numerous injurious
effects of phenol exposure, repeated application of dressings impregnated
with 5-10% solutions of phenol has produced acquired ochronosis, a
discoloration of collagenous tissue, which was described in 4 reports. 
[58-61] The discoloration occurred when phenol dressings were used to
treat skin ulcerations associated with the development of varicose veins.
The dressings were applied over periods ranging from 3 to 24 years.
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Prior to the 1940's, only a few cases of exposure to phenol in the
workplace had been reported. [20,29,62-66] Among these were 3 cases of
prolonged inhalation of phenol [63-65] with possible additional contact 
with the spilled liquid in 1 case [64] and 4 cases of contact with spilled 
liquid on the skin [20,29,62] including 1 fatal exposure. [20]
In 1872, Unthank [63] described the case of a farmer who inhaled
phenol vapor at unknown concentrations for 3 hours. The victim had
symptoms of giddiness and euphoria followed by convulsions and coma. 
Additional signs were stertorous breathing, lividity of face and neck, cold 
extremities, and a weak, irregular pulse. Following treatment and return 
to consciousness, the patient complained of giddiness, pain in the face and 
neck, gastric irritation, and a phenol taste. There was a gradual 
improvement with recovery in 4 days.
Hamilton, [20] in a 1917 report, attributed 2 poisonings, 1 fatal, to 
the absorption of phenol through the intact skin. The fatality occurred as 
a result of a chemist accidentally stepping into a phenol waste solution. 
The victim experienced tinnitus, dyspnea, vertigo, euphoria, and hysteria. 
The victim was allowed to leave in this condition, but he evidently soon 
lost consciousness as he was found dead on the road the next morning.
Examination of the body revealed a gangrenous leg below the knee.
In 1922, an employee wiping up the fluid spilled as a result of 
dropping a bushel of crude phenol developed signs and symptoms associated 
with absorption of phenol. [65] The victim collapsed a few minutes after a 
brief exposure. Thirty minutes later, the patient was comatose and
cyanotic with stertorous breathing, subnormal temperature, cold
extremities, slight burns on the right hand, and the odor of phenol on his
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breath. After treatment, recovery was complete in 2 days.
A report by McCord and Minster [29] in 1924 described the exposure of 
a shoe worker tokphenol contained in a marking ink spilled on her clothing. 
Injuries were second-degree burns on the face, neck, and breasts, followed 
by depression, fatigue, headache, a weak and rapid pulse, and collapse. 
Recovery was speedy following institution of treatment.
In 1939, Winkler [62] described a case in which a chemical worker was 
sprayed with a liquid containing 50% phenol, 35% cresol, and 10% xylene. 
The victim received severe burns of the hands, chest, face, and eyes. 
Examination of the eyes revealed edematous conjunctivae, corneal opacities, 
insensitivity to light, and hemorrhaging beneath the conjunctivae. 
Application of fluorescein dye produced intense coloration. The victim was 
euphoric, complained of headache, and passed a darkened urine which 
contained phenol and albumin. Winkler concluded that the patient had
suffered transitory kidney damage. The red blood cell count was initially
normal but decreased markedly to 2.3 million/cu mm in 10 days. Aside from
anemia, Winkler postulated damage to the blood-forming organs based upon an 
increased bilirubin concentration in the serum, slightly increased
leukocyte count of 17,000/cu mm, lymphocytosis, and monocytosis. Blood and 
kidney abnormalities disappeared upon treatment.
Prior to the early 1900Ts, phenol taken orally was a popular suicidal 
agent. [25,67-74] Its popularity declined markedly after 1900 because 
other poisons were considered to be less painful and were also more 
accessible. [26] Reid et al [59] noted that, in 1909 in the US, of the 
3,376 fatal poisonings in which the agents were known, 1,621 (48%) were due 
to phenol. Of the 1,621, 1,466 (88%) were suicides. With the decline of
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phenol as a suicidal agent since 1900, [26] cases of phenol poisoning by 
oral exposure have diminished. Since 1940, there have been two reports 
[75,76] involving three deaths from intentional phenol ingestion.
Effects on Humans
The most frequent adverse effects of phenol reported in humans are 
those from skin contact. Since the early 1940's, numerous investigators 
[27,76-99] have reported the injurious effects of phenol following 
inhalation, [88, 92,95,97,98], ingestion, [75,76] contact with the skin, 
[76-99] direct contact with the trachea during a tracheotomy, [91] and 
percutaneous injection. [81] Injurious effects following skin contact with 
resins containing phenol have been reported. [100-105] These signs and 
symptoms are listed in Table XII-6.
Early investigators [29,56,58,62,63,68,69,71,106-112] reported 
certain signs and symptoms which are not found in the more recent 
literature. These included abortion, [69,109] acquired ochronosis, [58-61] 
difficulty in swallowing, [56,68,69,71,106,107,111] and tinnitus. [58] 
Symptoms such as euphoria, delirium, and giddiness are reported as 
increased excitability by more recent investigators [86,88] while symptoms 
of depression have been more recently reported as stupor. [75]
Effects not found in earlier reports but noted by current investiga­
tors [77,85,89,93] include pigmentary changes in the skin, [93] damage to 
the pancreas, [84] skin cancer, [89] loss of weight, [92] and leukocytosis. 
[76] These reports probably reflect changes in medical terminology.
(a) Effects of Inhalation
Aside from Fuller's [56] 1869 report, only 5 reports were found
29
[88,92,95,97,98] on the inhalation of phenol. In 1971, Piotrowski, [97] in 
controlled experiments, exposed 7 men, aged 25-42, and 1 woman, aged 30, to 
phenol vapor at various concentrations either by inhalation or by 
absorption through the intact skin. The subjects passed a thorough medical 
examination prior to exposure. In 12 separate experiments, phenol at 6-20 
mg/cu m (1.5-5.2 ppm) was inhaled using a face mask connected to a chamber 
in which airborne phenol was generated dynamically from a vessel heated in 
a constant temperature bath. During each experiment, the concentration of 
phenol was determined hourly by sampling air directly from the inhalation 
and exhalation channels of the exposure masks and analyzing for phenol. 
The only dermal exposure to phenol during the inhalation studies was inside 
the masks. Subjects were exposed for 8 hours with 2 breaks of 0.5 hour 
each, one occurring 2.5 hours and the other 5.5 hours after the start of 
exposure. A 24-hour urine sample was collected prior to exposure. Urine 
samples were taken every 2 hours during exposure and ad libitum until the 
next morning after the exposure ceased.
Skin absorption studies [97] were carried out inside the previously 
mentioned exposure chambers at phenol concentrations of 4.8-5.3 mg/cu m 
(1.2-1.4 ppm), 9.3-9.7 mg/cu m (2.4-2.5 ppm), 24.8-25.3 mg/cu m (6.4-6.6 
ppm), and 22.3-26.1 mg/cu m (5.8-6.8 ppm), as determined by hourly sampling 
of chamber air. The subjects were clothed in underwear and denim overalls 
and placed in hammocks during the first, second, and fourth series of 
experiments and were naked during the third. In each case, subjects 
breathed fresh air through a face mask to exclude the inhalation of phenol 
vapor. Exposures were for 6-hour periods with 1 short.break in the middle. 
Urine samples were collected as in the inhalation experiments. Urine
samples in both series of experiments were analyzed for total phenol using 
the method of Porteous and Williams [113] as modified by Teisinger et al. 
[114] Phenol was collected from air, using 0.1 N NaOH in fritted bubblers, 
and analyzed by distillation of phenol in a manner similar to that used in 
the analysis of urine. The standard error of a single measurement was + 4% 
of the mean, and phenol recovery from air in 1 bubbler exceeded 95%.
Piotrowski [97] found that individuals exposed by inhalation retained 
60-88% of the inhaled dose. This percentage did not vary significantly 
with airborne phenol concentration but did decrease from about 80% at the 
beginning of exposure to about 70% at the end. There was a slight tendency 
for retention of phenol to increase after each 30-minute break in exposure. 
Urinary excretion increased rapidly during exposure and returned to normal 
within 16 hours after termination of exposure. Calculations showed that 99 
+ 8% of the inhaled dose was excreted in the urine. Individuals exposed 
through skin absorption excreted amounts similar to those exposed by 
inhalation, and excretion rates were about the same by either route of 
exposure. In the skin absorption experiments, clothed and naked subjects 
showed about the same excretion rates. The author [97] did not describe 
any adverse effects for any of the test subjects.
In 1972, Merliss [92] reported a gradual deterioration of the health 
of a 44-year-old laboratory technician who had been exposed to vapor 
containing phenol, cresol, and xylenol and who had often spilled phenol on 
his trousers. Spills resulted in skin irritation. Signs and symptoms 
noted included loss of appetite, darkened urine, and muscle pain in the 
legs and arms. He stayed away from his job for several months during which 
time his health gradually improved. He returned to the laboratory for a
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period of 45 minutes and had an immediate recurrence of muscle pain and 
subsequent darkened urine. He lost weight and exhibited an enlarged liver 
which was slightly tender to the touch. His urine remained dark for 
several weeks. His condition gradually improved over the next 3 months. 
Although his liver size and urine color had returned to normal and he had 
gained weight, it was reported that he had not completely recovered.
Petrov [88] reported 29 poisonings during a 3-year period in a group 
of employees who quenched coke with a waste water solution containing 0.3- 
0.8 g phenol/liter. Concentrations for phenol in air samples collected in 
work areas ranged from 0.5 to 12.2 mg/cu m (0.1-3.2 ppm). The author felt 
that phenol at concentrations from 8.8 to 12.2 mg/cu m (2.3-3.2 ppm) may 
have been implicated in the intoxications. No other measurements were 
reported in this area, and the nature of the phenol poisoning was not 
further characterized. The observed conditions were most likely produced 
by some substance in the effluents from either the waste water or the
coking process, but it is inappropriate to assume that these conditions 
were produced by phenol.
In documenting their Threshold Limit Value for phenol, [95] the
American Conference of Governmental Industrial Hygienists cited data given 
to them as a personnal communication by the Connecticut Bureau of
Industrial Hygiene. These data indicated that employees inside a
conditioning room for phenol-impregnated asbestos suffered marked 
irritation of the nose, throat, and eyes when exposed for intermittent 
periods of 50 minutes to a mixture of phenol at 48 ppm (about 200 mg/cu 
m) and formaldhyde at 8 ppm. Formaldehyde alone at 8 ppm has been shown 
to cause such irritation. [115-122]
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Ohtsuji and Ikeda [98] measured exposures to airborne phenol and uri­
nary phenol concentrations in samples from a group of Bakelite factory 
employees. Airborne phenol concentrations ranged from 0 to 12.5 mg/cu m. 
Samples of phenol in air were obtained at a rate of 2 liters/minute using 
two midget impingers containing 15 ml of 0.1 M borate buffer (pH 10.0). 
Total air volumes sampled ranged from 5 to 10 liters. Analyses for phenol 
were performed using Gibbs reagent. [98,123] Urine samples were collected 
before and after exposure and analyzed for total, free, and conjugated 
phenol using the Ikeda modification [124] of the Gibbs method. Urine 
samples were also analyzed for ethereal glucuronides and sulfates using the 
method of Bertolacini and Barney [125] as modified by Ohmori and Hara. 
[126] In addition, the specific gravity and creatinine concentration of 
urine were measured, the latter by the method of Ikeda and Ohtsuji. [127] 
Urinary conjugated phenol and total phenol adjusted to an average urine 
specific gravity of 1.018, due largely to the conjugated phenol fraction, 
increased with airborne phenol concentrations, but the concentration of 
free phenol varied little with changes in airborne phenol concentrations. 
Ethereal sulfates in the urine generally increased with increasing airborne 
phenol concentrations. These increases were observed during the shift, but 
decreases in these constituents to preexposure concentrations the following 
morning suggested that these employees readily conjugated and eliminated 
the phenol absorbed as a result of their combined inhalation and skin 
exposures. These results are in agreement with and appear to support 
similar conclusions made by Piotrowski, [97] who separately investigated 
the inhalation and skin absorption of phenol vapor.
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(b) Effects of Ingestion
Bennett et al [75] reported 2 suicide cases. The first case involved 
a 50-year-old morphine addict who had swallowed 2 oz (approximately 60 ml) 
of an 88% aqueous phenol emulsion. Forty-five minutes later, he was 
stuporous with cold and clammy skin and had a rapid and weak pulse, 
stertorous breathing with a phenol odor on the breath, constricted pupils 
which did not react to light, and rales in his lungs. An electrocardiogram 
showed auricular flutter with a variable auriculoventricular block. Lumbar 
puncture revealed normal spinal fluid. His urine was greenish with no 
albumin but, 12 hours later, there was marked albuminuria and cylindruria. 
Albuminuria persisted for 10 days. The patient responded to treatment 
except for nausea, vomiting, and diarrhea which continued during the first 
week. He recovered in 20 days. Constriction of the pupils may have been 
due to the intravenous injection of 0.5 g of morphine prior to phenol 
ingestion.
The second case [75] involved a 19-year-old woman who had ingested 15 
ml of liquefied phenol. Ninety minutes later, she complained of severe 
nausea and burning in the throat and epigastrium. Laryngoscopic 
examination revealed superficial burns and slight edema of the hypopharynx. 
Despite gastric lavage with olive oil and intravenous saline 
administration, she continued to be nauseated. One hour later, she began 
to vomit blood and to have diarrhea, passing copious amounts of blood with 
clots. She gradually became cyanotic and stuporous. Her blood pressure 
decreased markedly and her extremities became cold. She experienced 
periods of relapse and recovery during treatment but died 17.5 hours after 
the ingestion.
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In another report, [76] a woman committed suicide by ingesting 10-20 
g of phenol. She became comatose with partial absence of reflexes, pallor 
of the skin, accelerated respiration, weak and rapid pulse, and dilated 
pupils which did not react to light. Almost one hour after the ingestion, 
her heart and respiration stopped and, in spite of repeated attempts at 
resuscitation for two hours, she died. Autopsy revealed marked hyperemia 
of the tracheal and bronchial mucous membranes. Histologic examination 
revealed pulmonary and liver edema as well as hyperemia of the intestines.
(c) Effects of Skin Exposure
The skin represents a primary route of entry for phenol vapor, [97] 
liquid phenol [76,77,84,86,87,89,90,93,94,96] and solid phenol. [79] 
Phenol vapor readily penetrates the skin with an absorption efficiency 
approximately equal to that for inhalation. [97] Skin absorption can occur 
at low vapor concentrations, [97] apparently without discomfort. [79,96]
Liquid phenol in contact with the skin rapidly enters the bloodstream 
[77-79,82,84-87] and is responsible for the variety of signs and symptoms 
listed in Table XII-6. These signs and symptoms can develop rapidly with 
serious consequences, including shock, [76,82,84,85] collapse, [76,81,85] 
coma, [77,86] convulsions, [80,128] cyanosis, [76,78,83] and death. 
[76,79,84,86,87] Damage to internal organs has also been described. 
[76,79,82,85] In addition, the skin is often a site of contact for 
production of chemical burns and absorption of solid [79] or liquid phenol. 
[77-79,82,84-86,90,93,94,96,105] There is no evidence that allergic 
dermatitis results from exposure to phenol, but exposure to resins 
containing phenol has produced allergic dermatitis results. [100-105] 
Such allergic reactions can be caused by other agents such as formaldehyde
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in the resins, [100,102] the resin itself, [100,101 103,104] or some other 
product. [104] Discussions of phenolic resins are included in these 
criteria only when the resins are used or manufactured in such a way as to 
release free phenol. In such cases, phenol has been mentioned as the 
probable cause of the skin irritation. [105]
Gottlieb and Storey [129] have described pathologic findings in a 32- 
year-old somewhat obese man who accidentally spilled a strong solution of 
phenol over his scalp, face, neck, shoulders, and back. The authors stated 
that information on the onset of symptoms was not available but, had it 
been, in all probability it would not have been reliable. The victim, a 
chronic alcoholic, died within 10 minutes after contact with phenol. 
Pathologic findings related to phenol were coagulation necrosis of the skin 
and left eye, acute dermatitis venenata, acute phenol toxicosis, and acute 
passive congestion of the lungs, liver, spleen, and kidneys. There was 
moderate cerebral edema (possibly due to his chronic alcoholism). Other 
pathologic conditions, including chronic degeneration of the liver, 
kidneys, and heart, were also described. Samples of blood, brain, and 
stomach contents were analyzed for phenol. The blood contained 0.073% 
ethanol and 0.0037% phenol. The concentrations of phenol and ethanol in 
the stomach contents were nil. Skin and liver tissues were positive for 
phenol by Millón's test. The authors attributed the cause of death to a 
phenol toxicosis from absorption of phenol through the intact skin.
Caviness [84] reported the case of a 47-year-old diabetic woman who 
had been lax in her diet and insulin regimen for over 3 years. She 
developed an eczema on her toe to which she applied a 5% phenol in iodoform 
and zinc oxide ointment twice a day under a closed dressing. The toe
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showed marked edema and erythema, which soon extended to the ankle. She 
complained of a throbbing pain. Five days later upon admission to the 
hospital, she had a fever, and increased respiratory rate, pulse rate, and 
blood pressure. The toe was blue in some areas and red and edematous in 
others. Later, gangrene developed, causing severe pain and associated 
periostitis. Following amputation, the woman recovered.
Noury [81] reported a suspected case of rabies in a 49-year-old man 
who was given prophylactic inoculations of antirabies vaccine in 5 cc of a 
1% phenol solution every day for 15 days. The patient had a history of 
chronic alcoholism. For the first 10 inoculations, he did not notice any 
particular effect but, after the 11th, he collapsed. His pupils were 
constricted, his breathing was stertorous, and his pulse weak. He vomited, 
lost consciousness, and was taken to the hospital. He regained 
consciousness after 6 hours and remained in the hospital for 20 days. A 
permanent partial facial paralysis occurred as a result of the incident, 
but the author did not provide sufficient information to determine the 
cause of paralysis.
Satulsky and Halpem [90] described 3 cases of dermatitis venenata 
caused by the local application of a phenol-camphor ointment. The first 
case was that of a 28-year-old man who treated a self-diagnosed case of 
crab lice with a liquid preparation containing camphor and 4.75% phenol. 
Within two hours he felt a burning pain which increased in severity. The 
abdominal area was covered with a severe dermatitis with lurid erythema, 
marked edema, and numerous small, tense, clear vesicles throughout. 
Desquamation was evident around the umbilicus. The edges of the eruption 
were clearly marked. Also noted were a marked increase in local body
temperature, profuse serous exudation, maceration, and a tendency towards 
bullous formation. Covered and uncovered patch tests with the mixture on 
unaffected areas of the man's skin and on the skin of 2 volunteers elicited 
a primary irritant response in all cases within 30 minutes. The second 
case was that of a 26-year-old man who treated himself for tinea corporis 
on the abdomen with a pheno1-camphor solution. In 1 hour, he had severe 
burning, stinging, and pruritus; all of these symptoms increased in 
severity until his hospitalization the following day. Severe erythema and 
serous exudation were present. The edges of the eruption were clearly 
demarcated and slightly raised. Vesiculation and bullae were also
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accompanied by the exudation of a thick, white serum. Edema, erythema, and 
crusting were also present. The third case was that of a 24-year-old man, 
who treated paronychia on his fingers and toes with a phenol-camphor 
mixture which caused burning and pain within 45 minutes and lasted for 1-5 
hours. Erythema, vesiculation, crusting, fissuring, and oozing were 
present.
Hubler [78] cited the case of a 30-year-old woman who treated the 
ringworm between her toes with a camphor-phenol solution which caused 
marked edema and pain. One week later, her toes showed bilateral edema and 
a number of deep ulcerations. The patient was totally disabled for about a 
month.
In 1949, Cronin and Brauer [77] reported the case of a 10-year-old 
boy who had received first- and second-degree burns over 25-30% of his body 
surface. After being treated with a 2% phenol solution, he developed signs 
and symptoms of phenol poisoning, including darkened urine, increased pulse 
rate and body temperature, severe abdominal pain, stupor, cyanosis, local
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tissue necrosis, stertorous breathing, dyspnea, rales, frothing, and "pink 
mucus arising from the lungs." Two and one-half days after the initiation 
of treatment, the boy was comatose, with irregular respiration, fever, and 
increased pulse rate; he died within 3 days. Post-mortem examination
revealed burns, a yellow fluid in the pericardium, and spotty, firm, dark 
brown and red areas on the lungs, which also showed hypostatic pneumonia. 
Abnormal amounts of mucus were present in the trachea and bronchi, where 
the mucous membranes were hemorrhagic. The spleen was congested. The 
liver showed midzonal necrosis. The epithelial cells in the glomeruli of 
the kidneys showed marked parenchymatous degeneration, with loss of 
cellular configuration. The gastrointestinal tract showed acute 
congestion. A similar case was cited by Johnstone. [130]
Watorski [96] reported 2 cases of phenol poisoning in the workplace 
following skin contact with phenol. In the first case, a laboratory
technician suffered burns on both hands after spilling a 97% phenol
solution (containing cresol impurities). Shortly after the spill, he
washed his hands with 98% methanol and then with 20% sodium thiosulfate 
solution followed by soap and water. Later, he was treated by topical 
application of 20% sodium carbonate and a dressing with 30% castor oil 
ointment. Six hours later, he suffered fatigue, general weakness, and 
blurred vision. A day later, he had severe pain and continued weakness. 
Recovery occurred within several weeks of the accident. In the second 
case, a man died 5-7 minutes after the explosion of a metal container of 
crystalline phenol which was being heated by a battery of Bunsen burners. 
Trauma produced by the explosion could have contributed to his death.
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Evans [82] reported the case of an industrial employee who was 
involved in the spraying of weeds with a predominantly phenolic material 
which was the effluent of a chemical plant. This material contained 43.5% 
phenol, 20% water, 14% cresols, 11.5% low-boiling organics probably 
aldehydes, and 11% high-boiling organics— probably resinous material 
according to the author. The skin of both thighs (7 inch x 4 inch and 6 
inch x 2 inch areas, respectively), of the scrotum, and of the penis was 
exposed to the spray. Washing with large amounts of warm water was started 
immediately and continued for 30 minutes. This was followed by swabbing 
with ethanol for 10 minutes. The warm water wash and ethanol swabbing were 
repeated. The employee developed symptoms of shock within 30 minutes after 
exposure. He had reduced body temperature, a weak and irregular pulse, an 
accelerated respiratory rate, stertorous breathing, and constricted pupils 
which showed a slow response to light and slow accommodation. His left leg 
had convulsive movements for 30 minutes. There was minimal liver damage, 
as indicated by an increased serum bilirubin at 1.7 mg% (approximately 1 mg 
% is normal) and by a positive Van den Berg reaction with a direct/indirect 
quotient of 40%. Other tests for liver function were normal. Urine was 
not analyzed for phenol until 4 days after exposure, at which time it was 
negative. Recovery was complete, and the patient was released from the 
hospital 7 days later.
Johnstone and Miller [85] described a case of industrial exposure to 
phenol in an ink-manufacturing plant where an employee spilled phenol on 
his leg, abdomen, and chest. Following immediate flushing with water, he 
went to a physician's office where he collapsed and died within 15 minutes. 
Post-mortem examination revealed extensive first- and second-degree burns
on his body, hyperemia and edema of the lungs, and marked hyperemia and 
edema of the kidneys, pancreas, and spleen.
Duvemeuil and Ravier [86] reported that an employee accidentally 
spilled 4-5 liters of 78% aqueous phenol on himself. Despite immediate 
irrigation with alcohol, he became comatose and exhibited superficial skin 
burns. He died shortly thereafter.
Hinkel and Kintzel [87] observed 2 cases of newborn-babies exposed to 
phenol. One died 11 hours after the application of a bandage containing 2% 
phenol to the umbilicus. The other was treated for a skin ulcer with a 30% 
phenol-60% camphor mixture (Chlumsky’s solution) and then experienced 
circulatory failure, cerebral intoxication, and methemoglobinemia. The 
infant recovered following a blood transfusion.
Telegina and Boiko [93] reported vitiligoid dermal changes in 12 
employees in a motor-oil additives-production plant where concentrations of 
phenol vapor were 0.055-3.33 mg/cu m, hydrocarbons 3.3-24.6 mg/cu m, 
hydrogen sulfide 0.11-0.78 mg/cu m, sulfur chloride 0.05-0.28 mg/cu m, and 
carbon monoxide 3.3-26.6 mg/cu m, and where contact of the exposed skin 
surfaces of the employees with phenol and other irritating substances was a 
distinct possibility. One employee had been employed for 2.5 years, 1 for 
3 years and 7 months, 9 for 6-10 years, and 1 for more than 10 years; 3 
employees were 20-29 years, 6 were 30-39 years, and 3 were 40-49 years of 
age. In those employees in whom this pigmentation abnormality had existed 
for 2-5 years, the skin had vitiligoid depigmentation spots on the chest, 
the waist, and the dorsa of the hands and feet, with the largest spots 
occurring at skin folds. The edges of the spots were not clearly 
demarcated. Accompanying these large spots were numerous small white ones
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distributed in clusters. In those individuals who had developed this 
depigmentation more recently, isolated maculae of depigmentation were 
evident. Pruritus was rarely reported. In dyschromic individuals, 
eosinophilia, monocytopenia, elevated local tissue temperature, 
susceptibility to prolonged spasms of the cutaneous capillaries of the 
hands, extensive prolonged dermographia of the chest, marbleization of the 
extremities, induration and turgescence of the larger and intermediate 
blood vessels, and excessive perspiration and cyanosis of the extremities 
occurred. Furthermore, the author noted that employees over 40 appeared to 
develop secondary and intercurrent skin diseases more readily than did 
younger employees. It also has been noted [131-134] that several other 
phenolic compounds can cause similar depigmentary changes.
Abraham [79] reported that an 18-year-old laboratory assistant 
developed gangrene of the thumb after a 30-minute exposure to crystals of 
pure phenol which were present inside a rubber glove. The phenol rendered 
his thumb insensitive. He did not receive treatment for 41 hours following 
exposure. A clear demarcation between the gangrenous area and the normal 
skin appeared 26 days after exposure. The necrotic tissue was removed 
surgically, and the patient recovered. No systemic disorders were noted.
In 1940, Stevens and Callaway [89] described a case involving an 
epithelioma with basal- and squamous-cell components which had resulted 
from the continued self-application of a salve made of phenol and ergot to 
an area on the back. The man, a 72-year-old druggist, had applied this 
"secret formula" daily to one area of the back where the eczematoid 
dermatitis was more resistant to treatment. His skin in the middle of the 
lower back was loose, wrinkled, and warm, and contained a large fungating
mass, 15 cm in diameter. Borders were rolled and, in some areas, there was 
deep ulceration. In other areas, epitheliomatous hyperplasia and 
granulations were evident. The lesion was extremely vascular and bled 
easily. A biopsy showed a neoplastic, invasive growth. Microscopic 
examination of the tissue revealed it to be a basal-cell and squamous-cell 
epithelioma. The authors reported that there was no evidence of 
metastasis. The patient refused treatment either by radiation or excision. 
The investigators properly attributed the cancer to the continued 
irritation of the skin rather than to any specific property of phenol.
(d) Thresholds of Perception
Leonardos et al [135] using an odor panel determined the phenol odor 
threshold to be 0.047 ppm. This threshold represented the lowest concen­
tration to which all 4 trained panelists, selected from a pool of 15 
experienced odor panelists, responded positively. Phenol was so tested for 
at least 5 different concentrations.
Makhinya [136] measured the phenol odor thresholds of 19 people and 
the lowest range of concentrations for the detection of phenol by odor was 
0.022-0.094 mg/cu m (0.006-0.024 ppm). Phenol at concentrations of 0.016- 
0.078 mg/cu m (0.004-0.020 ppm) was not perceptible by odor for the group 
tested. Mukhitov [17] obtained similar results using a group of 14 people. 
The odor threshold for phenol ranged from 0.022 to 0.184 mg/cu m (0.006- 
0.048 ppm). The highest concentration of phenol not perceptible by odor 
was 0.0175 mg/cu m (0.005 ppm).
Six 5-minute inhalation exposures to phenol at 0.0155 mg/cu m (0.004 
ppm) produced an increased sensitivity to light (p < 0.01) in each of 3 
dark-adapted subjects [17] who were selected from an original group of 14,
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based upon their minimal odor thresholds of 0.029, 0.073, and 0.184 mg/cu 
m, respectively. Further tests on the original group revealed that 15- 
second exposures to phenol at 0.024 mg/ cu m (0.006 ppm) elicited the
formation of conditioned electrocortical reflexes in 4 additional subjects.
Tests with 0.0155 mg phenol/cu m (0.004 ppm) elicited the latter response 
in 3 of the 4, while 0.0137 mg/cu m (0.0036 ppm) elicited no response. In 
these experiments, light was used as the unconditioned reflex stimulator 
which elicited alpha-rhythm desynchronization as measured on an 
electroencephalograph. Inhalation of phenol was used as the conditioned 
stimulator, and desynchronization was the index of reflex elicitation.
(e) Metabolism
Ruedemann and Deichmann, [137] using 1 group of 5 male medical
students and 3 other groups made up of volunteers, conducted experiments on 
skin absorption of phenol. Each group member received 1 or more 
applications of 50 g calamine lotion containing 1 g of phenol (2% phenol) 
applied over 75% of the body. The medical students received a single 
application; the second group received 2 applications, 90 minutes apart; 
the third group received 3 applications, 90 minutes apart; the fourth group 
received 4 applications, 90 minutes apart. Blood samples were drawn at 2- 
hour intervals for 1-3 days and analyzed for phenol using the method of 
Deichmann and Schafer. [138] From the time of the final application,
subjects did not remove their underwear for periods of 24-48 hours, at 
which time each took a shower and donned clean clothing. After allowing a 
2- or 3-week period for their blood values to return to normal, these same 
subjects were similarily exposed to 1, 2, 3, or 4 1-g doses of phenol
contained in 21 g of phenol-camphor-liquid petrolatum (4.75% phenol). In
both tests, preexposure concentrations or free phenol in the blood of all 
20 subjects averaged 0.15 mg/100 ml and increased to an average of about 
0.4 mg/100 ml during each of the tests. Preexposure concentrations of 
conjugated (protein-precipitated) phenol in the blood of all subjects 
averaged 0.35 mg/100 ml in both experiments. Conjugated phenol concen­
trations in blood increased to averages of 1.1, 1.65, 1.9, and
approximately 1.9 mg/100 ml, respectively, for the groups receiving 1, 2,
3, and 4 calamine applications and to averages of 0.9, 1.2, 1.7, and 1.5 
mg/100 ml, respectively, in the groups receiving 1, 2, 3, and 4 applica­
tions of phenol-camphor-liquid petrolatum. Both the free and the 
conjugated phenol concentrations in blood returned to preexposure values 
within 24 hours. The subjects noted a soothing and cooling sensation 
followed by a feeling of warmth after application of the test formulation. 
There were no indications of systemic intoxication at any time during or 
shortly after the tests. The investigators noted from these experiments 
that phenol readily penetrated the human skin, and that detoxication by 
conjugation apparently was initiated immediately.
There have been various estimates made of the "normal" concentrations 
of phenol in blood and urine, (see Table XII-10,11) Aside from the values 
cited by Ruedemann and Deichmann, [137] estimates of "normal" free phenol 
in blood ranged from none or traces to 4 mg/100 ml. For conjugated
(protein-precipitated) phenol in "normal" human blood, estimates ranged 
from 0.1 mg/100 ml to 2 mg/100 ml, and for total phenol in "normal" human 
blood, values range from 0.15 to 7.96 mg/100 ml. [138-150] The
concentrations of free and conjugated phenol in the blood of those exposed 
to dermal applications of 2% and 4.75% phenol lotions overlapped the range
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of other reported norms. [137] However, with the exception of two reports, 
[137,138] data presented in Table XII-10 were reported prior to 1939. 
Based upon more recent work and the propensity for phenol to combine with 
protein, [137] one would expect the concentration of free phenol in the
blood of unexposed subjects to be lower than the concentration of
conjugated phenol. However, several investigators [145-148] have reported 
the opposite case. The variation in absolute amounts of phenol reported 
also depend on the analytical method used; however, even with the exclusion 
of results from dubious analytical methods, [141-146] "normal" blood values 
cover a considerable range and no precise estimates of normal, free, or 
conjugated blood phenol concentrations can be made.
Total phenol concentrations in "normal" urine have been found to 
range from 0.5 to 81.5 mg/liter. [97,128,151— 158] The specific gravity used 
to correct for "normal" urine in the British literature is usually 1.016 
g/cu cm, and in the US literature it is usually 1.024 g/cu cm. Some 
investigators use the average specific gravity for the urine obtained from 
a test population as "normal" urine. In some reports, there are no 
indications of which correction factor, if any, might have been used. The 
variation for urinary phenol concentrations in Table XII-11 can be 
attributed in part to individual variation between test subjects, variation 
between analytical methods, and the correction factor used. Single 
exposures to phenol vapor at up to 6.8 ppm via either inhalation or skin
absorption for periods of up to 8 hours produced no more than about 100 mg
total phenol/liter of urine. [97] By comparison, industrial exposures to 
phenol at 10 mg phenol/cu m (2.6 ppm) were reported to result in a urinary 
phenol concentration of 262 mg/liter. [98] Assuming respiration of 8 cu m
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of air during the work shift and 100% absorption (80 mg), excretion of the 
total amount absorbed in approximately 300 cc of urine would result in the 
reported concentration. This suggests that phenol is rapidly collected and 
excreted in urine.
Ikeda and Ohtsuji [127] observed considerable variation in normal 
urinary phenol concentrations, depending upon the analytical method used. 
Folin and Denis [151] found differences in urinary phenol excretion between 
people on high- and low-protein diets and noted [159] that both salicylic 
acid and aspirin produced an increase in the concentration of phenol in 
human urine. The latter finding was recently substantiated in a report by 
Fishbeck et al. [160] Biologic monitoring of urinary phenol concentration 
as a precise index of exposure to phenol has limited usefulness because of 
the considerable variation and overlap in the ranges for urinary phenol 
output in individuals considered to be unexposed as well as in individuals 
considered to have been exposed. In addition, phenol is a metabolite 




Acute toxicity studies have been conducted on a variety of species 
including the cat, [162-164] dog, [162,165-167] goat, [167] guinea pig, 
[168], pig, [167] rabbit, [163,169-171] and rat. [163,169,172] Results of 
these studies by species, routes of administration, and conditions of 
exposure to phenol are summarized in Table XII-12.
In 1915, Macht [162] reported that oral administration of phenol to
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cats at doses of from 50 to 100 mg/kg body weight caused death in all 
animals tested. Intravenous injection of phenol in water at a dose of 50 
mg/kg also killed all animals tested. [164] Subcutaneous injections of 
phenol in 0.9% sodium chloride solution were administered to cats at doses 
of from 1.2 to 15 mg/kg each day for 5 days. One of 3 cats administered 
phenol at a dose of 30 mg/kg each day for 3 days died 2 days after the 
final dose while the surviving cats experienced inappetence and diarrhea. 
[164] Lesser doses of phenol caused loss of appetite. Phenol at 80 mg/kg 
administered by subcutaneous injection of 10% phenol in olive oil killed 
approximately 50% of a test group of cats. [163]
Macht [162] conducted experiments to determine the minimal dose of 
phenol which would cause death in cats and dogs in from 1 to 2 hours. For 
cats this dose was from 50-100 mg/kg while for dogs it was about 500 mg/kg. 
All animals left untreated died at these doses. However, comparisons of 
immediate treatments by lavage using plain water, a strong solution of 
sodium sulfate, or a solution of 10% ethanol in water showed that sodium 
sulfate was most effective, followed in effectiveness by plain water. 
Treatment with ethanol aggravated the apparent effects and hastened death. 
The author recommended that use of alcohol to treat cases of phenol 
ingestion be strongly discouraged.
Bond and Haag [165] found that 300 mg of camphor administered orally 
to 3 fasted dogs along with doses of phenol at 54 - 64 mg/kg body weight 
resulted in death for all animals while administration of phenol at doses 
of 37-83 mg/kg in 3 fasted dogs produced no fatalities. A seventh dog 
given 300 mg of camphor alone also survived. In a separate experiment 
using 14 dogs fasted for 24 hours and given a dose of 20 mg of morphine
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sulfate, 10 of 11 dogs died when given phenol at doses from 3 to 8 g/kg 
while 2 of 3 dogs survived when given doses from 1 to 2 g/kg. Haskell et 
al [166] administered oral doses of liquified phenol at 320-420 mg/kg to 
healthy adult dogs. The dogs were fasted for the immediately previous 24 
hours, but were allowed free access to water. Prior to phenol 
administration, each dog was given a subcutaneous injection of morphine 
sulfate. Two dogs survived, and the remaining dogs died in 1-6 days.
Oehme and Davis [167] observed neuromuscular irritability, coma, and 
convulsions (but no deaths) as toxic effects of phenol given orally at 100 
mg/kg to dogs, goats, and pigs. They also reported frequent intravascular 
hemolysis and darkened urine containing protein, hemoglobin, and bilirubin. 
The authors considered these findings indicative of kidney damage.
Chassevant and Garnier [168] gave intraperitoneal injections of 
phenol to 6 guinea pigs at doses of 30-300 mg/kg using a 10% aqueous 
solution of the sodium salt of phenol. The average dose was 170 mg/kg. At 
high doses, the guinea pigs died in a few hours but, at low doses, deaths 
occurred in 1-5 days. A few minutes after injection, there was usually a 
crisis which began with a generalized shaking that developed into broader 
movements until the animal could no longer stand. This was followed by a 
complete muscular atonia. Hypothermia was a constant observation. 
Autopsies performed immediately after death revealed intense congestion of 
the visceral and parietal peritoneum, the abdominal viscera, and 
particularly of the kidneys and adrenals. In another series of 
experiments, 5 guinea pigs were given intraperitoneal injections of phenol 
at doses of from 200 to 1000 mg/kg using 10% phenol solution in olive oil. 
While 2 of the 5 animals survived, the physiologic responses of the guinea
pigs to phenol and the pathologic findings were similar to those for the 
sodium salt of phenol. [168]
Cosgrove and Hubbard [171] conducted experiments to determine the 
effects of phenol on the eyes of rabbits and to test the efficacy of 
decontamination techniques. One drop of phenol at either 87%, 50%, 20%, or 
10% in glycerin was applied to the eyes of rabbits. The eyes were 
completely destroyed by 1 drop of 87% phenol, and applications of one drop 
of the more dilute solutions of phenol produced similar destructive 
effects. When the eyes of the test animals were irrigated immediately with 
either water or 4% sodium sulfate, there was no damage. Immediate 
irrigations with 25% ethanol in water resulted in some slight permanent 
opacities. If irrigation with water was delayed for 10 seconds or longer 
after application, corneas became opaque in 40% of the animals treated with 
87% phenol. However, 70% of the animals developed opacities when treated 
with 50% phenol followed by delayed irrigation. The authors also reported 
that animals treated with either 20% or 10% phenol had responses similar to 
those of the animals treated with 50% phenol, but this observation of more 
opacities produced by weaker solutions was not further explained. Delayed 
irrigations with 4% sodium sulfate were less effective than water in 
preventing opacities.
Experiments to establish a range of toxicity were carried out on the 
rabbit using a variety of oral doses of phenol in water. [173] The 
studies indicated that there was no difference in the toxicity of phenol 
when the same amount was administered in either a concentrated or a dilute 
solution. Administration of phenol at a dose of 620 mg/kg caused death in 
all rabbits tested. An intraperitoneal (ip) LD50 of 620 mg/kg was found
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for rabbits injected with 5% aqueous solutions of phenol, and the 
intravenous (iv) LD50 for rabbits was approximately 180 mg/kg. [173] In 
other experiments, the abdominal skin of rabbits was exposed for one hour 
to aqueous phenol solutions or emulsions under a latex covering. [173] 
Blood phenol concentrations were determined after exposure using the 
diazotized p-nitroaniline method of Deichmann and Schafer. [138] The 
concentration of phenol in blood did not show a proportional increase 
relative to the amount of phenol contained in the exposure solutions, and 
phenol concentrations in blood were 1.1-5.2 mg/100 ml using 7% phenol, 1.2-
5.1 mg/100 ml using a 75% emulsion of phenol, and 2.2-6.0 mg/100 ml using a 
95% emulsion of phenol. In a range-finding experiment, [170] rabbits were 
clipped of body hair, and the skin of individual rabbits wars exposed to 
phenol at single doses ranging from 10 to 6,400 mg/kg using 1.0, 5.0, or 
20% solutions of phenol applied under an impervious cuff and allowed to 
remain for 24 hours. Large doses involved application of from 70 to 100 ml 
of solution to each rabbit under the cuff which covered the entire portion 
of the body between the appendages. Three rabbits receiving doses of 
1,600, 3,200, or 6,400 mg/kg of phenol died within two hours of
application. Rabbits exposed to phenol at 10 to 800 mg/kg survived.
Deichmann and Witherup [163] conducted experiments on rats, rabbits, 
and cats to determine the acute effects of phenol. Equal numbers of males 
and females were used in the individual experiments. The 100% lethal dose 
for cats given subcutaneous injections of a 10% phenol solution in olive 
oil was 80 mg/kg. In experiments using rats to determine differences in 
susceptibility to phenol as a function of age, 10-day-old rats were more 
susceptible to phenol administered either cutaneously or by ingestion when
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compared to 5-week-old or to adult rats. Cutaneous applications of 3,000 
mg phenol/kg were lethal to 9 of 20 (45%) adult rats, to 5 of 20 (25%) 5- 
week-old rats, and to 13 of 20 (65%) 10-day-old rats. Oral administrations 
of 600 mg phenol/kg were lethal to 12 of 20 (60%) adult rats, to 9 of 30 
(30%) 5-week-old rats, and to 18 of 20 (90%) 10-day-old rats. An LD50 for 
adult rats given 10% phenol in olive oil was found to be 1,500 mg/kg. In 
several experiments with rabbits, the effects of phenol either by oral 
intubation, injection into the stomach through the abdominal wall, 
intravenous injection, or by skin contact were investigated. Oral doses of 
phenol ranged from 280 to 940 mg/kg as either melted crystals or as 
solutions containing from 2 to 90% phenol. There was little difference in 
the toxicity of either dilute or concentrated solutions when administered 
in similar amounts orally. Lethal effects were generally produced by
phenol at a dose of 620 mg/kg and occasionally by phenol at a dose of 420
mg/kg.
Ernst et al [164] dipped the tails of 10 rats in a 4.75% phenol- 
camphor-liquid petrolatum solution 1 hour/day for 30 of 42 days. Tails 
were washed and dried after each exposure. Another group of 10 rats was 
similarly exposed to water. Both groups showed occasional mild hyperemia, 
which was less noticeable in controls. No other significant difference 
between the two groups was observed.
Deichmann and Witherup [163] exposed four rabbits to 4.75% phenol- 
camphor-petrolatum solutions (250 mg/kg) for 5 hours/day, 5 days/week, for
18 days. Two of the rabbits were wrapped in bandages. After each 5-hour
period the bandages were removed, and all rabbits were washed with soap and 
water. A mild hyperemia developed but disappeared after washing. Mild
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tremors occurred during the 18-day period. In a continuation of the 
experiments, 24 rabbits were divided into 6 groups of 4 each and exposed to 
aqueous solutions containing phenol at 1.18, 2.37, 3.56, 4.75, 5.93, and
7.12% concentrations. These exposures were equivalent to doses of phenol 
at 64, 130, 190, 250, 320, and 380 mg/kg, respectively. Two of the four 
rabbits in each of the groups exposed to the four lowest concentrations 
were bandaged, while no bandages were us^d in the two highest exposure 
groups. Rabbits exposed to 1.18% phenol showed no signs of irritation or 
of systemic effect. The group exposed to 2.37% showed no signs of skin 
irritation, but occasional mild tremors were observed. Those rabbits 
exposed to 3.56% and 4.75% phenol had hyperemia and mild tremors which 
developed one hour after the start of each exposure for all animals in the 
group. Hyperkeratosis was observed in one of the four animals in the 4.75% 
group. Those animals exposed to the two higher concentrations of 5.93 and 
7.12% phenol had local tissue necrosis and severe tremors. One of the four 
exposed to 7.12% phenol died after the sixth application.
In 1950, Deichmann et al [169] found that approximately 50% of the
rats whose tails were dipped in 6.6% aqueous phenol solutions for 8 hours
died; 2.75% phenol in aromatic liquid petrolatum and 12.5% phenol with 
10.86% camphor in aromatized liquid petrolatum produced similar results. 
They also found that tails dipped in 1.78% phenol in liquid petrolatum or 
in 4.15% aqueous phenol for 8 hours became gangrenous.
In 1970, Conning and Hayes [172] determined the LD50 to be 0.625
ml/kg (670 mg/kg) for percutaneous exposure of rats to liquified phenol 
(melted at 40 C) by both occlusive and nonocclusive techniques (shorn
back). Severe muscle tremors with twitching developed into generalized
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convulsions with subsequent loss of consciousness and prostration 5 10 
minutes after administration of the dose in all animals. Severe 
hemoglobinuria developed 45-90 minutes after the application with severity 
increasing as a function of the administered dose. In addition, all 
animals developed skin lesions and edema with subsequent tissue necrosis 
and discoloration. Pathologic examinations revealed evidence of severe 
kidney damage in all animals. The lowest dose applied was 0.1 ml/kg.
(b) Chronic Exposure
Various investigators have conducted experiments to determine effects 
produced in animals by chronic exposure to phenol by inhalation, 
[17,28,174] ingestion, [173] or skin contact. [175-179] Data from these 
experiments are presented in Tables XII-13-18.
(1) Inhalation
In 1944, Deichmann et al [174] exposed 12 guinea pigs, 6
rabbits, and 15 rats to phenol vapor at concentrations ranging from 100 to 
200 mg/cu m (26-52 ppm) for 7 hours/day, 5 days/week. No control animals
were used. All animals were exposed in a single 600-liter chamber with
phenol vapor generated from 2 gas-washing bottles containing a phenol 
solution and immersed in an oil-coated, constant-temperature water bath 
maintained at 25 C. Airborne phenol concentrations were estimated by
analysis of grab samples using a colorimetric diazotization procedure. 
After 20 exposures over a period of 28 days, 5 guinea pigs died and the 
remaining 7 were killed on the 29th day. Prior to termination of the 
exposures, some animals showed weight loss, respiratory difficulty, and 
signs of paralysis. At autopsy, pathologic examinations revealed evidence 
of extensive necrosis of the myocardium, acute lobular pneumonia, vascular
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damage, and hepatic and renal damage. Analysis of blood at autopsy by the 
method of Deichmann and Schafer [138] showed average free phenol 
concentrations of 1.0 mg/100 ml, average conjugated phenol concentration of 
0.4 mg/100 ml, and average total phenol concentration of 1.4 mg/100 ml.
In a continuation of the inhalation experiments, [174] 6 rabbits 
exposed 63 times in 88 days did not show signs of distress. After 27 
exposures (37 days), average blood concentrations were 0.5 mg free 
phenol/100 ml, 0.7 mg conjugated phenol/100 ml, and 1.2 mg total phenol/100 
ml. When the animals were killed at 88 days, blood phenol analyses were 
essentially unchanged. Microscopic examinations revealed evidence of 
lobular pneumonia, chronic purulent bronchitis, degenerative changes in 
pulmonary blood vessels, myocardial degeneration, and indications of liver 
and kidney damage. In general, damage was less severe than that found in 
the guinea pigs.
Rats exposed 53 times in 74 days showed no signs of distress and upon 
autopsy revealed no evidence of adverse effects. No blood analyses were 
reported for rats. [174]
In 1961, Sandage [180] exposed 10 monkeys, 50 rats, and 100 mice to 
phenol at 5 ppm (19 mg/cu m), 8 hours/day, 5 days/week, for 90 days. An 
equal number of animals of each species, housed in identical chambers, 
served as controls. Phenol vapor was introduced using sintered glass gas 
washing bottles maintained at elevated temperature. Phenol vapor air 
streams were reduced in temperature, and the air saturated with phenol was 
introduced into the chambers by mixing with fresh air. Phenol 
concentrations were determined by absorbing the phenol from 2 liters of air 
in 20 ml of 0.1 N NaOH and analyzing this solution colorimetrically with
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diazotized p-nitroaniline and sodium carbonate. Periodically hematology 
tests, urinalysis, blood chemistry measurements, kidney function tests, 
stress tests, and measurements of body weight were performed. Pathologic 
examinations upon autopsy at the termination of exposure showed no 
differences between exposed and control animals (with 95% confidence) with 
the exception of a slight weight gain in exposed rats and monkeys and an 
increased stress test endurance for exposed mice.
(2) Reproduction and Growth
Heller and Pursell [173] reported the results of controlled 
oral exposures to phenol, in which 10 groups of rats were allowed 0, 100,
500, 1,000, 3,000, 5,000, 7,000, 8,000, 10,000, and 12,000 ppm phenol in
their drinking water. For the groups allowed water containing from 0 to
8.000 ppm phenol, volumes of water consumed were noted and food was 
analyzed for phenol content. Phenol from food represented a significant 
fraction of dietary phenol intake, especially in the lower exposure groups. 
Growth, fecundity, and general condition were noted for 5 generations of 
rats in the groups receiving 100, 500, and 1,000 ppm phenol, for 3 
generations in the 3,000- and 5,000-ppm groups, for 2 generations in the 
7,000- and 8,000-ppm groups, and for 1 year in the 10,000- and 12,000-ppm 
groups. All observations were within normal limits in the groups allowed
5.000 ppm or less. The growth of young from the group allowed 7,000 ppm in 
water was stunted. At concentrations of 8,000 ppm and above, mothers did 
not provide the ordinary care for their young, and many of the young died. 
At 10,000 ppm, the offspring died at birth. At 12,000 ppm, there was no 
reproduction and, in the summer, the older rats allowed 10,000 or 12,000 
ppm died sooner than did controls.
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Mukhitov [17] exposed 3 groups of 15 rats continuously for 61 days to 
phenol vapor at approximately 0.011 mg/cu m (0.003 ppm), 0.11 mg/cu m (0.03 
ppm), and 5.2 mg/cu m (1.4 ppm), respectively. A fourth group of 15 rats 
served as controls. Animals were exposed dynamically in 100-liter 
chambers. The air was sampled once or twice each day. The general
condition and the weight of the animals were determined daily, and motor 
chronaxy, urinary coproporphyrins, and whole blood cholinesterase
activities were measured periodically. Animals exposed to phenol at 0.011 
mg/cu m were of good general health and their condition was 
indistinguishable from controls in all categories. Rats exposed to phenol 
at 0.11 mg/cu m (0.03 ppm) were also in excellent health, but exhibited a 
slightly shorter extensor muscle chronaxy (p < 0.01) and an increase in 
whole blood cholinesterase activities in comparison with controls. Rats 
exposed to 5.2 mg phenol/cu m were more sluggish than controls and showed a 
lower rate of weight gain (p < 0.05), had a shortened extensor and
lengthened flexor muscle chronaxy (p < 0.01), and showed increased whole
blood cholinesterase activities (p < 0.01).
(3) Skin Cancer
Salaman and Glendenning [175] performed experiments to test
the effect of phenol as a sclerosing agent on the production of skin tumors 
in 4 groups of 20 male mice using "S" strain albinos. Two groups were 
pretreated by application to the whole back of 0.2 ml of 0.15% 9,10-
dime thyl-1,2-benzathracene (DMBA) in acetone. Three weeks after the DMBA 
application, one of the pretreated groups and one untreated control group 
were treated with 0.1 ml of 5% phenol in acetone at two alternating sites 
on the lower back once a week for 32 weeks. The second group receiving
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DMBA pretreatment was treated with 0.025 ml of 20% phenol in acetone at 
four sites on the back in rotation once a week for 24 weeks while a control 
group was treated with 20% phenol in a similar manner for 32 weeks. All 
mice were inoculated on the tails with sheep lymph vaccine as a precaution 
against ectromelia. The hair from the back was clipped before treatment 
and at intervals when necessary. Throughout treatment, 20% phenol in 
acetone continued to produce local ulcerations in both the test and the 
control groups. The ulcerations required almost the entire 4 weeks to heal 
before the next application scheduled for the site. Tumors began to appear 
in the group treated with DMBA after 8 applications of 20% phenol in 
acetone while tumors appeared in the control group after 24 applications of 
20% phenol. No tumors developed in the group exposed only to 5% phenol in 
acetone. The group pretreated with DMBA and exposed to 5% phenol in 
acetone developed 13 tumors after 13 weeks, and there were 9 tumors on 4 
mice out of 14 surviving after 45 weeks. Tumor yields and the experimental 
conditions are summarized in Table XII-15. The authors [175] concluded 
that, under the conditions of these experiments, a solution of 20% phenol 
in acetone produced skin ulcerations and had a strong promoting action on 
tumor development and a weak carcinogenic action. A solution of 5% phenol 
in acetone was found to have a moderate promoting action, but no 
carcinogenic action. No unexposed controls, no controls with DMBA alone, 
and no controls for application of acetone were reported.
Boutwell and Bosch [176] conducted experiments with one group of 
albino male mice of the Sutter strain and several groups of albino female 
mice of the Sutter, Holtzman, CAF1, and CH3 strains to evaluate the skin 
tumor-promoting potential of phenol following a single application of 9,10-
58
dimethyl-l,2-benzanthracene (DMBA). Sutter strain mice were selectively 
bred for three generations for susceptibility to development of tumors 
after a single application of DMBA followed by croton oil. [181] Benzene 
solutions of phenol or DMBA were applied to the backs of mice by test group 
as indicated in Table XII-16, and tumor yields were noted for periods of up 
to 52 weeks. DMBA was applied in a single application of 75 f i g (0.025 ml 
of a 0.3% solution in benzene) one week prior to initiation of treatments 
with phenol. For DMBA applications, the fur was shaved from the test area 
of the back. Because of the possibility of mechanical irritation and
damage to papillomas, the mice were not shaved after initiation of phenol 
exposures. Phenol was applied at concentrations of 5% or 10% in benzene 2 
times/week while one group received only DMBA with no subsequent treatment 
with phenol or benzene and a second group received DMBA pretreatment 
followed by 0.025 ml of benzene 2 times/week for 20 weeks.
One group receiving treatment with 10% phenol in benzene 2 times/week 
for 52 weeks did not receive pretreatment with DMBA. Repeated application
of 10% phenol in benzene following pretreatment with DMBA caused benign
tumors to appear rapidly and in large numbers while carcinomas appeared
late. Phenol alone was capable of inducing tumors in females of the 
DMBA/croton oil-tumor-susceptible Sutter mice, and in female mice of the 
Holtzman strain. Using female mice of the DMBA/croton-oil-tumor 
susceptible Sutter strain, Boutwell and Bosch [176] conducted additional 
experiments in which a single application of 75 jug of DMBA in 0.025 ml of a 
0.3% solution in acetone was used as an inititator for tumor formation, and 
phenol was applied 2 times/week in concentrations from 5% to 20% in various 
solvents including acetone, 30% ethanol in acetone, benzene, and dioxane.
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Tumor yields, survival, duration of observations, and treatment conditions 
are given in Table XII-17. Tumor yields increased with increasing phenol 
content of solvents and total amounts of phenol applied. Tumor yields were 
zero for acetone, benzene, or 30% ethanol in acetone solvent controls using 
mice pretreated with a single application of DMBA and observed over a 12- 
week period
Wynder and Hoffmann [177] conducted experiments to compare the tumor 
promoting action of phenol and phenol derivatives identified in tobacco 
smoke. The phenol used in their initial test was especially prepared and 
"chemically pure" while in later experiments, phenol was purified by 
distillation over zinc dust. Reagent grade acetone was used as a solvent 
for the administration of either phenol, 3,4-benzo[a]pyrene (BaP), or DMBA. 
Six-week-old Swiss Millerton mice were used in seven experiments in which 
acetone containing phenol at either 5% or 10% concentration was applied 2 
or 3 times/week to the backs of animals which had been treated with a 
single application of DMBA one week prior to the start of the phenol tests. 
The dorsal hairs of the mice were shaved before the single DMBA 
application.
In other experiments, [176] about 5 n g  of BaP at a concentration of 
0.005% in acetone was applied 3 times/ week to the backs of 6-week-old- 
Swiss Millerton mice. On alternate days, 5% phenol in acetone was applied 
to one group 2 times/week, and 10% phenol in acetone was applied to a 
second group 2 times/week. No phenol or acetone was applied to a third 
group maintained as a BaP-exposed control. The dorsal hair of these mice 
was not shaved to avoid any additional skin irritation. Tumor yields and 
conditions for these experiments are presented in Table XII-18. With a
single application of DMBA, exposure to phenol increased the yield of 
tumors and caused an earlier onset of tumors. In addition, tumor yield was 
greater and tumor onset was earlier for each of the 2 DMBA-exposed groups 
receiving 10% phenol when compared to a DMBA-exposed group receiving 
applications of 5% phenol. Applications of phenol caused earlier onset of 
tumors compared to time of onset in the control group exposed to BaP alone.
Van Duuren et al [178] treated the shaved dorsal skin of 20 female 
ICR/Ha Swiss mice with 0.3 mg phenol in 0.1 ml acetone 3 times/week for 1 
year beginning 4 days after pretreatment with a single application of 150 
f i g  DMBA in 0.1 ml of acetone. Twenty female ICR/Ha Swiss mice serving as 
controls were subjected to a single application of 150 f i g  DMBA. Four of 
the phenol-exposed mice (20%) developed papillomas during the year with 
observation of the first papilloma after 167 days of exposure. One animal 
developed a squamous carcinoma after 355 days of exposure. The DMBA 
controls had two (10%) papillomas, with observation of the first papilloma 
after 247 days and one carcinoma (5%) observed after 373 days. Results and 
conditions of these experiments are presented in Table XII-18.
Van Duuren et al [179] reported an additional experiment in which 3 
mg of phenol in 0.1 ml acetone and 5 f i g  of 3.4-benzo(a)pyrene in 0.1 ml 
acetone were applied 3 times/week over a 460-day period to the backs of 
female ICR/Ha Swiss mice. When compared to a control group receiving only 
BaP in acetone, the phenol treatment produced fewer tumors. Tumor yields 
and conditions for this experiment are also presented in Table XII-18.
(c) Metabolism
Once phenol enters the body, it may be rapidly eliminated in the 
urine [167,173,182-192] as the conjugated phenylglucuronide [167,173,182-
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192] or phenylsulfuric acid products. [167,182,183,187-192] It may also 
be oxidized to catechols [191], quinones, [191] and carbon dioxide and 
water, [182,185] or excreted unchanged in the urine,
[167,182,183,185,189,190,192] feces, [173,183,193] or exhaled air. [183] 
Conjugation occurs primarily in the liver, [183,184,190, 191,193-195] but 
it also occurs in the intestine, [184,193,195] kidneys, [194, 195] spleen, 
[195] pancreas, [193] and extracellular fluid. [184,193] Oxidation to 
catechols and quinones occurs primarily in the liver. [191] Deichmann and 
Keplinger [196] presented two figures (see Figures XII-1 and XII-2) which 
combine the findings of Deichmann [183] and Parke and Williams [191] to 
show the respective fates of sublethal and lethal oral doses of phenol in 
the rabbit.
The extent and nature of the conjugation of phenol have been shown to 
be functions of diet, [173,184,189,194,197] dose, [183,187], route of 
entry, [184] degree of animal fatigue, [198] and body temperature. [199] 
The metabolism of tyrosine [173,184,189,193,197] or metabolism of salicylic 
acid [160,192] can result in significant endogenous production of phenol. 
Williams [187] has stated that the extent of conjugation to phenylsulfuric 
acid decreases rapidly with increasing dose, and he expressed the opinion 
that the formation of phenylsulfuric acid was largely a function of 
available sulfate. [187]
In general, signs of intoxication appear only after absorption of 
phenol in amounts sufficient to overwhelm the capacity of the body to 
detoxify or otherwise eliminate phenol. The precise dosage at which 
adverse effects begin to occur is uncertain. Excessive doses of phenol in 
animals have been shown to depress the vasomotor centers of the brain,
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[164,167,172,200,201] producing, in some studies, motor disturbances and 
blood pressure changes of sufficient magnitude to induce cardiac arrest, 
respiratory failure, [167,172,185, 190,192] and coma followed by death.
[162,163,165,166,169,170,172]
Correlation of Exposure and Effect
Solutions of phenol were shown (see Table XII-6) to rapidly penetrate 
human skin. [81,86,96,111,202,203] Skin contact by humans with solutions, 
emulsions, or pure preparations containing 80-100% phenol for as little as 
5-20 minutes (see Table XII-6) resulted in death. [96,115,202,204] 
Exposure of eczematous skin to a phenol solution as dilute as 2.5% caused 
coma in 3 minutes. [Ill] Contact with a 43.5% phenol solution for a period 
of less than 1 minute produced shock despite repeated 30-minute irrigations 
with copious amounts of water followed by swabbing with ethanol. [81] 
Seventeen daily dermal applications of a 1% phenol solution resulted in 
coma in an 82-year-old woman. [128] Exposure of skin contact areas as 
small as a portion of a thumb for 30 minutes caused gangrene, [79] while 
contact of "pure carbolic" with a portion of the scalp and cheek caused 
death in 5-10 minutes. [204] Thus, repeated contact with dilute phenol 
solutions or even brief contact with concentrated phenol solutions posed a 
hazard to life, even if the contact area was relatively small.
Chronic skin contact with 5% phenol in oil was reported to have 
caused acquired ochronosis [58-61] over periods of 3-30 years, [58,59] and 
death after a period of 12 years. [60] In addition, Stevens and Callaway 
[89] reported a single case of an invasive squamous cell epithelioma in a
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72-year-old man who had applied a salve of phenol and ergot to his back 
daily for 20 years.
Reports of occupational exposure and of controlled experiments (see 
Table XII-6) showed that phenol vapor can enter the human body both by 
inhalation [17,95,97,98,135,136] and through the intact skin [97] (see 
Table XII-6), and is rapidly detoxified and eliminated by conjugation 
[95,97,98] and excreted in the urine. [95,97,98] Conjugation has been 
associated with the formation of ethereal sulfates [95,98] and 
glucuronides. [98] Ohtsuji and Ikeda [98] reported that concentrations of 
conjugated phenol in the urine increased following exposure of humans to 
phenol from as little as 0.6 mg/ cu m (0.16 ppm) to as much as 12.5 mg/cu m 
(3.3 ppm) without any significant increase in the concentration of free 
phenol. Piotrowski [97] conducted experiments on inhalation and skin 
exposure to phenol vapor separately. He found that humans exposed to
phenol at vapor concentrations of 6-20 mg/cu m by inhalation showed
increased total urinary phenol. Skin exposure to phenol vapor at 5-25 
mg/cu m also caused an increase in total urinary phenol. The increase of 
urinary phenol was about the same for inhalation as for skin exposure. In 
both cases, urinary phenol concentration returned to normal within 16 hours 
after termination of exposure. Denim overalls or other clothing did not 
hinder the absorption of phenol vapor through the skin. [97] No ill 
effects were reported from the combined skin and inhalation exposures to 
phenol at 12.5 mg/cu m (3.3 ppm), [98] from inhalation of phenol at 25
mg/cu m (6.8 ppm) phenol, or from skin exposure to phenol at 20 mg/cu m
(5.2 ppm) for up to 8 hours. [97]
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Skin absorption from human contact with solid phenol produced tissue 
destruction and gangrene at the site of contact following 30 minutes of 
direct contact with the solid. [79]
Cosgrove and Hubbard [171] reported that the eyes of rabbits were 
completely destroyed by 1 drop of 87% phenol in glycerin. If, however, the 
eyes were irrigated immediately with water, corneas remained clear. If 
irrigation of the eyes was delayed 10 seconds or longer after application, 
corneas were damaged in 40% of the animals tested. One drop of 50% phenol 
in glycerin left in the eyes 10 seconds or longer before irrigation with 
water resulted in only 30% of the animals recovering and having transparent 
corneas within 3 or 5 days. Use of 20% or 10% phenol in glycerin gave 
similar results. In general, if the eyes of treated animals were irrigated 
immediately with water or 4% sodium sulfate, all animals had transparent 
corneas. Using 25% ethanol for immediate irrigation resulted in some 
slight permanent opacities. Delayed irrigations with 4% sodium sulfate 
were less effective than water in preventing opacities.
Ingestion of phenol by humans caused abdominal pain and numerous 
signs and symptoms listed in Table XII-6. Principal effects of ingestion 
included at least one or more of the following: a burning sensation in the
throat [68,69,77,205] followed by abdominal pain, increased irritability, 
headache, absence of comeal reflexes, collapse, convulsions, [68] coma, 
and death. [70,75,76] The amounts of phenol required to produce such 
severe reactions in humans were relatively small, and data in Table XII-9 
show that ingestion of as little as 4.8 g of pure phenol caused death in 10 
minutes. [205] The ingestion of 4.3 g phenol 3-4 times in a single day 
caused a burning sensation in the throat, giddiness, cold and profuse
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perspiration, a weak pulse, and darkened urine, [56] while by contrast a
single ingestion of 1.3 g phenol [206] or 0.96 g phenol taken 3-4 times/day
[56] produced no immediate ill effects.
No report was found of acute or chronic human exposure to phenol
vapor or aerosol by inhalation. No epidemiologic study of an employee
population exposed to phenol by inhalation has been reported.
Phenol can be derived from endogenous as well as exogenous sources, 
and animal experiments provided a more precise definition of the metabolic 
fate of phenol. As shown in Figure XII-1, subacute doses of phenol were 
rapidly eliminated largely by conjugation to phenylsulfuric acid and 
phenylglucuronic acid, by oxidation to catechols and quinones or to carbon 
dioxide and water, [182,185] or by excretion as free phenol. [167, 
182,183,187,189,190,192] Excretion occurred primarily in the urine 
[167,173,182-192] with small amounts being excreted in the feces 
[173,183,193] or in exhaled air. [183] When the functional capacity for 
detoxification was exceeded, vasomotor centers of the brain could be 
depressed [164,167,172,200,201] producing alteration of blood pressure 
[200,207,208] and motor disturbances [164,167,172,200,201] capable of 
inducing cardiac arrest with respiratory failure [172,185,190,192] followed 
by death. [162-170,172]
The lowest doses producing death in animals as shown in Table XII-12 
were 50-100 mg/kg by oral administration [162] and 20 mg/kg by intravenous 
injection in the cat, [164] 320 mg/kg by ingestion in the dog, [166] 150 
mg/kg by intraperitoneal absorption in the guinea pig, [168] 380 mg/kg by 
skin absorption in the rabbit, [169] and 420 mg/kg by ingestion in the 
rabbit. [163] The LD50 for the rat through skin absorption is 670 mg/kg.
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[172] Deichmann and Witherup [163] reported the lethal dose for 
approximately 50% of the animals as 80 mg/kg by subcutaneous injection in 
the cat, 620 mg/kg by subcutaneous injection or 620 mg/kg by 
intraperitoneal injection in the rabbit; 340 mg/kg by ingestion in the rat, 
and as 2.75% phenol in petrolatum applied to the skin of a rat for 1 
hour/day for 3 days. The lowest doses of phenol to attack the vasomotor 
center and produce signs were 4.9 mg/kg by intravenous injection [164] and
1.2 mg/kg by subcutaneous injection in the cat, [164] 700 mg/kg by
intravenous injection in the dog, [167] 100 mg/kg by intravenous injection 
in the goat, [167] 150 mg/kg by intraperitoneal injection in the guinea 
pig, [168] 100 mg/kg by intravenous injection in the pig, [167] 130 mg/kg
by skin contact, [169] 280 mg/kg by ingestion, [163] and 26-52 ppm (100-200 
mg/cu m) by inhalation in the rabbit, [174] and 107 mg/kg by skin 
absorption in the rat. [172]
Inhalation exposures (see Table XII-13) of 26-52 ppm (100-200 mg/cu 
m) phenol 7 hours/day, 5 days/week, produced 5 (42%) deaths in a group of 
12 guinea pigs after 29 exposures. [174] Upon autopsy, pathologic 
examination revealed necrosis of the myocardium, lobular pneumonia, 
vascular damage, and hepatic and renal damage. Rabbits similarly exposed 
63 times in 88 days showed no signs of illness or discomfort but had 
lobular pneumonia, chronic bronchitis, vascular damage, myocardial 
degeneration, liver damage, or kidney damage at post mortem examination. 
[174] Rats exposed at 26-52 ppm (100-200 mg/cu m) phenol 53 times in a 
period of 74 days showed no microscopic evidence of adverse effects. [174] 
No controls, however, were used. Monkeys, mice, and rats were exposed to 
phenol at 5 ppm for 8 hours/day, 5 days/week, for 90 days without any
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adverse effects. None of 15 rats receiving 53 exposures showed any signs 
of illness or discomfort, and no pathologic findings were reported. [180]
In contrast, Mukhitov [17] found a significant (p < 0.01) decrease in rate 
of weight gain for rats exposed to phenol at 1.4 ppm (about 6 mg/cu m ) . 
Heller and Pursell [173] found that phenol at 7,000 - 12,000 ppm in 
drinking water adversely affected growth, fecundity, and general conditions 
of rats.
Odor thresholds for phenol in air in all persons so tested (see Table 
XII-7) were found to be 0.091 mg/cu m, [136] 0.178 mg/cu m, [135] and 0.182 
mg/cu m. Phenol has warning properties by odor at concentrations far below 
the concentrations at which toxic effects occur. Mukhitov [17] obtained 
similar results finding an odor threshold for phenol ranging from 0.022 to
0.184 mg/cu m (0.006-0.048 ppm).
Carcinogenicity, Mutagenicity, and Teratogenicity
Heller and Pursell [173] (see Table XII-14) allowed groups of rats to 
drink water containing phenol at 0-12,000 ppm. The group allowed phenol at
5,000 ppm in water had no adverse effects over 3 generations. Stunted 
growth was evident in the young of the group exposed to phenol at 7,000 ppm 
in water over 2 generations. In the group allowed phenol at 8,000 ppm in 
water for 2 generations, mothers would not care for their young which then 
died prematurely. The offspring of the rats allowed phenol at 10,000 ppm 
in water died at birth. The group allowed phenol at 12,000 ppm in water 
did not reproduce, and many adults died prematurely in hot weather. This 
study did not indicate any specific teratogenic properties of phenol.
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Salaman and Glendenning, [175] Boutwell and Bosch, [176] Wynder and 
Hoffmann, [177] and Van Duuren et al [178] showed that phenol promotes skin 
cancer in mice. In addition, Boutwell and Bosch [176] and Wynder and 
Hoffmann [177] reported that phenol is a weak skin carcinogen in mice. 
However, all of these studies did not provide for evaluation of effects 
produced by the solvents used and, in some cases, for the pretreatment of 
the albino mice with a known carcinogen, either DMBA or BaP. Conditions of 
these experiments, [175-179] do not reflect industrial experience with 
phenol, and the studies were carried out with phenol dissolved in various 
organic solvents, including benzene, acetone, dioxane, and a mixture of 30% 
ethanol in acetone. Results of these mice studies suggest that phenol 
functions primarily as a nonspecific irritant and may be capable of 
promoting tumors. There is no evidence that phenol acts as a specific 




Sampling and Analytical Methods
Phenol and substituted phenols have commanded the attention of 
analytical chemists for more than a century, and a large number of 
publications, in both theoretical and applied research, may be found in the 
general analytical chemical literature. In 1926 and 1927, Gibbs [209,210] 
published comprehensive reviews of the literature dealing with tests for 
phenol and noted that the number of tests exceeded 100. The bibliography 
to these papers contained references to more than 250 papers, many of them 
from the German literature in the latter years of the 19th century. 
However, modern industrial experience with phenol is substantially 
different, and most of these early reports are only of historical interest.
Almost all of the methods described by Gibbs are colorimetric tests,
and virtually all of the spectrophotometric methods in use today are
included in his classification scheme. [209,210] In the nearly 50 years 
since Gibbs' papers, many modifications and improvements in techniques
using the reagents he described have been made, but relatively few new
methods have been added. Gibbs classified all tests as dye reactions, 
halogen reactions, reactions with salts of metals, or a final mixed group 
which consisted of methods not belonging in the first three groups. The 
majority of the methods in use today would have been classified by Gibbs as 
dye reactions, which rely on the spectrophotometric determination of a 
color intensity produced with phenol and a reagent system. In a more 
recent review of colorimetric methods for determining phenols, Snell and 
Snell [211] described several reagents useful in phenol analysis and, in
addition, made specific recommendations for analyzing urine, blood, and 
other biologic samples, as well as air, water, sewage, and various 
commercial preparations. Feigl [212] also described several color tests 
suitable as spot tests for phenol. A review of the literature dealing with 
the analysis of phenol, but not necessarily related to air analysis in the 
workplace, reveals that the most widely used reagents have been Gibbs' 
reagents (2,6-dibromoquinonechloroimide), [4,13,97,98,124,213-217] 4-
aminoantipyrine, [49,215,216,218-232] diazotized aromatic amines, 
[138,157,215,220-225,228,233-243] and diaotized sulfanilic acid. [4,13,244- 
246] Other authors have reported methods based on ultraviolet 
spectrophotometry [213,215,216, 221,222,247-256] and measurement in both 
the near-infrared [257] and the conventional infrared [215,258-260] 
regions. A number of electrometric procedures have also been used to 
determine phenol, including potentiometric titrations, [261,262] volta- 
metric determinations, [263] and oscillopolarography. [264] Chemilumines- 
cence has also been used as the basis for a method described by Ponomarenko 
and Amelina [265] in which luminol (3-aminophthalhydrazide) is the chemilu- 
minescent material. Still other investigators have performed photometric 
titrations, usually in nonaqueous media. [266-268]
Unless there are precautions to separate phenol from other compounds, 
and in particular from phenol derivatives, most of the above methods are 
not specific for phenol. For the specific determination of phenol, a 
preliminary separation is usually required. Depending upon the sample 
composition, cleanup procedures generally involve separations by extraction 
and may require use of chromatographic techniques; separations have been 
performed by means of paper, [252,269-271] thin layer, [217,235,272-276]
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and column chromatography. [248-252,277,278] Separation or extraction does 
not constitute a determination of phenol but must be followed by analysis 
of phenol by an independent method.
Gas chromatography (GC) is perhaps the most convenient method for 
separation and simultaneous determination of phenol and phenol derivatives. 
A variety of GC techniques has appeared in the general literature. 
[50,152,154,232,252,259,275,279-294] In most of these techniques, isolation 
and concentration of the phenolic fraction of the samples is necessary to 
eliminate potential interferences prior to introduction into the
chromatograph. Although phenolic compounds may often be separated and 
analyzed by selected GC procedures without modification or preparation of 
derivatives, some investigators have prepared methyl aryl ethers, [280,295] 
phenoldiethylphosphate esters, [294] acyls, or more complex ethers [291] to 
facilitate separation and analysis.
Numerous analytical procedures are described for the determination of 
phenol in mixtures with a variety of substances, including hydrocarbon 
solvents, [296] gasoline, [247] wood smoke, [248] coal tar, [259] whiskey, 
[252] cigarette smoke, [234,235,275,280,281,295] and, of course, water.
[214,215,227,228,231,232,254,279] Analytical methods applied to the
analysis of either water or cigarette smoke are particularly useful, as
these methods, with appropriate modifications may often be applied to 
analysis for phenol in workplace air. Standardized methods developed for 
the analysis of phenol in water have been tested many times and are likely 
to be quite reliable. The American Society for Testing and Materials 
(ASTM) recommends several colorimetric and gas chromatographic methods for 
determining phenolic compounds in water. [232] Similar methods are also
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recommended in Standard Methods for the Examination of Water and 
Wastewater. [279]
Analysis of biologic samples for phenol has also been an area of 
interest. Phenol and phenol derivatives are naturally occurring substances 
found in blood, urine, and in a variety of samples of biologic origin, 
[194,240,297,298] and are related to both normal [267,299] and abnormal 
metabolism. [267,300] However, most earlier literature and some current 
studies generally have not been concerned with exposure to phenol in the 
workplace but instead have attempted to define the roles of phenols in 
health and disease. [152,241,246,240,288,301] Phenol has long been 
recognized as a toxic substance, and reports from the forensic toxicology 
literature contain numerous methods for determination of phenol in 
specimens obtained from humans. [138,242,302]
In general, most phenol analyses currently performed on biologic 
samples are intended to show exposure to benzene, rather than to phenol. 
[303] Exposure to benzene results in increased urinary phenol excretion, 
and there are numerous methods for the determination of phenols in urine. 
[152,154,157,230,243,287] In contrast, relatively little interest has been 
shown in measuring biologic concentrations of phenol in relation to phenol 
exposure, but several investigators have suggested that such analyses are 
indeed useful in assessing exposure to phenol [97,98] or phenol 
derivatives. [304]
Sampling and analysis of air to determine phenol content have been 
performed in connection with air pollution studies as well as in-plant 
determinations related to industrial hygiene investigations. Air pollution 
studies include a number of surveys of atmospheric phenol concentrations,
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[49,221-223,238,239,305,306] analyses of vehicular exhaust products, [32, 
221,222,225,226,255,271] and analyses of other air-pollution sources. 
[221,222,294] Many of the methods use colorimetric reagents, including 
diazotized paranitroaniline, [210] paraaminodimethylaniline sulfate, 
[49,305] aminoantipyrine, [49,220-226,229,237] chloroparanitrophenol, [237] 
and piperonyl chloride. [225,306] Ultraviolet spectrophotometric methods 
have also been used, [221,222,225,255] and a number of GC methods have been 
described. [32,271,283-286]
After collection of a workroom air sample, most industrial hygiene 
methods rely on spectrophotometric measurement of a phenol-dye complex 
using techniques developed for phenol in tissue or liquid samples. Jennings 
[9] and Zhitkova [307] described the use of Millon's reagent, a mercury- 
containing mixture which forms a colored compound with phenol, in the 
analysis for phenol in workplace air samples. Lovelock [244] was among the 
first to use diazotized sulfanilic acid for determination of phenol in air, 
and other investigators [4, 245] used a similar analytical procedure in 
later years. Fukuyama et al [233] used the so-called Moir reaction, 
utilizing diazotized paranitroaniline to produce a red color, and this 
reagent was also recommended by subsequent investigators. [308] Other 
spectrophotometric methods used for the analysis of phenol in workplace air 
include those based on nitration, [309] the use of several stable diazonium 
salts, [243,310,311] the Gibbs method, [13,213] and nitroso formation. 
[312] In addition to procedures involving analysis of a colored complex, 
ultraviolet absorption measurements have also been used by several 
investigators. [213,253]
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None of the above methods is specific for phenol, and it has been the 
practice in industrial hygiene to determine "total phenols" or, more 
accurately, -.hose substances which react with a given reagent rather than 
to attempt to limit the analysis to phenol. In using such methods, the 
underlying assumption is that either it is unnecessary to separate phenol 
derivatives or phenol is the only compound likely to be present.
One of the problems in the determination of phenol in air in contrast 
to other materials is the method of collecting the sample. It has been 
shown that phenol can exist in the air as a vapor, an aqueous aerosol, or 
in association with particulate matter. [221,222] An air sampling method 
for total phenol must collect all phases. Frequently, phenol is assumed to 
be present as a vapor and is collected by absorption in water, 
[9,244,245,307,310,308] alkaline solution, [4,233,243,309] or a bicarbonate 
solution. Ethanol solutions have also been used. [213] Phenol has also 
been collected by adsorption onto silica gel. [243] Smith et al [221,222] 
collected phenol on activated carbon, but this method of sampling was not 
applied to in-plant atmospheres.
A GC method [313] has been developed for NIOSH. Although this method 
has not been field-tested, it has been shown to be, specific for phenol, 
subject to certain limitations inherent in all GC procedures. It is 
suitably accurate and precise for quantitative analysis of phenol.
Control of Exposure
Reported injuries produced by phenol exposures, occupational and 
otherwise, have primarily resulted from either skin contact or ingestion. 
The rapid rate at which phenol is absorbed through the skin, resulting in
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severe injury or fatal results, is well documented. [81,86,96,112,170,202 
204] The eye can be damaged by contact with small quantities of phenol, and
this has been amply demonstrated in the rabbit using 10-87% solutions of
phenol in glycerin. In some instances, occupational injuries said to have 
been produced by skin contact with phenol [79,81,86,96,129,202,204] may 
also have involved vapor inhalation.
Quantitative data on phenol vapor concentrations associated with 
human effects due to exposure to phenol are scarce, [88,97,98] and the few 
reports containing quantitative data have involved low concentrations of 
the vapor. Piotrowski [97] has shown that phenol vapor is readily absorbed 
through the respiratory membranes and the skin, but absorption of the vapor 
through the skin is slower than by inhalation. Although there are no 
reports of severe injuries or fatalities resulting from exposure to phenol 
vapor in the industrial setting, prolonged skin exposure or inhalation of 
phenol should nevertheless be prevented.
Equipment, processes, and procedures for handling or using phenol 
should be designed and engineered to prevent all employee contact with 
phenol in any form. Total enclosure of processes and materials, with 
appropriate venting for pressure or vacuum relief, is desirable. When
routine operating, servicing, or maintaining of a production system is
required, provisions must be made to protect employees by the use of 
personal protective devices, adequate ventilation, and good work practices 
including spill prevention, cleanup, and prompt, safe disposal of material 
wastes. In addition, specific practices to be applied to the handling of 
phenol are as follows:
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(1) Remote control or automation of operations can be used 
effectively to remove employees from the proximity of operations where 
contact with phenol or inhalation of vapor would be most likely to occur.
(2) Pure phenol is a solid at 25 C, and all pipelines for transfer 
of phenol liquid should be steam-traced or otherwise designed and operated 
to ensure that phenol does not solidify in the lines. Similarly, all vent 
pipes from tanks and equipment should be steam-traced, [2,314] or designed 
and operated to prevent solidification.
(3) Personal protective clothing, shoes, and equipment must be used 
together with good work practices wherever there is a possibility of skin 
or eye contact with phenol (Chapter I).
Experience has shown that in many instances the concentration of 
phenol vapor in air is controlled adequately by the usual dilution 
ventilation of the workplace. Given the amount, method, and rate at which 
phenol is used in the workplace environment, the volume of air exhausted 
during the work shift, and the rate at which phenol may be vaporized 
depending on room temperature, appropriate calculations or air sampling and 
analysis should be performed to characterize any likely exposures to phenol 
vapor. At 25 C (77 F), the vapor pressure of phenol is sufficient to 
produce an equilibrium concentration (saturated air) of 462 ppm, and at 41 
C (106 F), the melting point of phenol, the equilibrium concentration is 
1,710 ppm. These equilibrium concentrations are not likely to occur in the 
breathing zone of an employee. However, there is sufficient vapor pressure 
[314] at temperatures ordinarily encountered in the work environment for 
the development of concentrations of airborne phenol in excess of the 
recommended environmental limits, particularly in enclosed or poorly
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ventilated spaces.
Increased general dilution ventilation can be used to increase the 
volume of air and rate of flow, thereby decreasing the concentration of 
phenol in the workplace to a safe airborne concentration. Where feasible, 
removal of phenol by local exhaust ventilation close to single or isolated 
sources of emission is preferred over general dilution ventilation.
Properly designed and functioning local exhaust ventilation can capture and 
prevent contaminants from reaching the breathing zones of employees or from 
being disseminated throughout the work areas. In employing exhaust
ventilation for such control, certain recommended practices [315] and 
design and operating fundamentals [316] should be followed. Regular
inspection and maintenance of the ventilation system are necessary for its 
continued effectiveness. Local exhaust ventilation should also be used for 
the control of phenol vapor emissions from hot processes.
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V. DEVELOPMENT OF STANDARD
Basis for Previous Standards
The American Conference of Governmental Industrial Hygienists (ACGIH) 
has recommended an 8-hour TWA concentration of 5 ppm (approximately 19 
mg/cu m) as the threshold limit value (TLV) for phenol (with a skin 
notation). The TLV for phenol was first established at 5 ppm in 1952. A 
skin notation was added in 1961, and there has been no change in the TLV 
through 1975. The ACGIH supports its limit in its Documentation of the 
Threshold Limit Values for Substances in Workroom Air [95] as follows. 
"Deichmann (1) reported results of animal experimentation in . which guinea 
pigs were severely injured by inhalation for 20 days of phenol vapor at 
concentrations of from 25-50 ppm. Post mortem evidence of acute toxicity 
to the lungs, heart, liver, and kidney was found. According to unpublished 
data from the Connecticut Bureau of Industrial Hygiene (2) intermittent 
industrial exposure (5-10 minutes per hour) inside a conditioning room for 
phenol-impregnated asbestos resulted in marked irritation of the nose, 
throat, and eyes. The average phenol concentration in the room was 48 ppm, 
although formaldehyde (8 ppm) also was found. Urine sulfate ratios were 
79.4 and 86.7 percent. Employees at the same plant, continuously exposed 
during winding operations, experienced no respiratory irritation, although 
the odor of phenol was noticeable. The average concentration found was 4 
ppm. Urine sulfate ratios averaged 74%. Due in part to its low 
volatility, phenol does not frequently constitute a serious respiratory 
hazard in industry. (3) Formerly its use as an antiseptic in surgery 
resulted in numerous cases of sub-acute or chronic poisoning among surgeons
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and their assistants. (4) Urinary excretions of 2 gm per day by patients 
have been reported. (4) Absorption of 2 gm of phenol could result from 8 
hours’ inhalation at about 50 ppm. According to Thomas and Back (5), the 
TLV of 5 ppm provides a sufficiently large factor of safety to prevent 
systemic poisoning if skin absorption is avoided." (Note: Numbers 1
through 5 in parentheses within the quotation are citations and correspond 
in the order given to references 174, 317, 308, 196, and 318 in this
document. Primary references cited are the animal studies of Deichmann et 
al, [174] Thomas and Back, [318] and the unpublished human data from the 
Connecticut Bureau of Industrial Hygiene. [317] The human data include 
conditions which may have been produced, at least in part, by the high 
airborne formaldehyde concentration reported to be present).
The present federal standard for phenol based upon the 1968 TLV [319] 
is an 8-hour TWA of 5 ppm phenol (skin).
Other countries and various states in the United States have 
established standards for phenol. These are listed in Table XII-19.
The Czechoslovak Committee of MAC, in their Documentation of MAC in 
Czechoslovakia, [320] present values shown in Table XII-20. The standard 
is supported in a translation as follows: "We believe on basis of observa­
tions in USSR and reports and standards from abroad that no hazard of 
chronic poisoning threatens in mean MAC and no hazard of acute poisoning in 
peak MAC. The comparatively small vapour tension of phenol and its 
distinct smell causes only isolated occupational poisonings by inhalation. 
The considerable etching effect of phenol on skin and possibly percutaneous 
resorption require care when handling liquid phenol especially in hot 
state."
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Ryazanov, [8] in supporting the Russian ambient air standard, 
concludes that the limit of allowable concentration of phenol in the air of 
work departments of production plants and factories of 5 mg/cu m (1.3 ppm) 
was not only low enough to prevent chronic poisoning but was also far above 
the threshold of odor perception.
Basis for the Recommended Standard
To protect the health of employees and to provide a safe working 
environment, it is essential to prevent skin or eye contact, inhalation, 
and ingestion of phenol. The recommended standard prohibits skin or eye 
contact and requires use of protective clothing made of rubber, neoprene, 
plastic, or other material impervious to phenol. Face shields, chemical 
safety goggles, or a full facepiece on respirators to provide eye 
protection are requried. Overexposure by inhalation is prevented by 
specifying an environmental limit and a ceiling limit for phenol in air 
which are values not to be exceeded. Exposures in excess of the airborne 
concentrations of phenol specified in Table 1-1 are prevented by the use of 
appropriate respiratory protective devices. Ingestion of phenol is 
prevented by work practices which prohibit smoking, drinking, or eating in 
work areas where phenol is present. In addition, medical surveillance is 
required for employees who are occupationally exposed to phenol. 
Occupational exposure has been defined as exposures to phenol at airborne 
concentrations exceeding one-half the recommended time-weighted average 
concentration limit.
To protect employees and to reduce the likelihood of injury, 
employers are required to provide first-aid services including deluge
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showers and eyewash fountains in areas where phenol is used.
Crystalline phenol has produced gangrene after 30 minutes of skin 
contact. [79] Such contact is possible, despite phenol's irritant 
properties, because of its local anesthetic action. [79] Phenol in 
solution has been shown to rapidly penetrate human skin. 
[82,86,96,111,112,202,204] Phenol solutions containing 50-100% phenol (see 
Table XII-6) have caused death after skin contacts as brief as 5-20 
minutes, [96,129,202,204] 2.5% phenol solution applied in a dressing over
the human body caused coma in 3 minutes, [111] and a 43.5% phenol solution 
accidently sprayed on the thighs, scrotum, and penis for a period of less 
than 1 minute caused shock despite repeated treatments consisting of 30- 
minute irrigations with copious amounts of water followed by swabbing with 
ethanol. [81]
Chronic contact with solutions as dilute as 1% phenol caused coma in 
an 82-year-old woman with eczema after 17 daily applications of phenol in 
calamine lotion. [129] Daily contact with phenol at an unknown 
concentration in an ergot salve over a period of 20 years induced a case of 
invasive epithelioma in an elderly man. [89]
Concentrations as dilute as 5% phenol have been shown to promote 
cancer in mice after pretreatment with DMBA. [175-178] (see Table XII-15). 
However, Van Duuren et al [179] found a reduced prevalence of tumors in 
mice exposed 3 times/week to 3 mg phenol applied concurrently with 5 f i g  
benzo(a)pyrene (BaP) as compared to mice receiving similar doses of BaP 
without phenol. Boutwell and Bosch [176] and Wynder and Hoffmann [177] 
produced a single malignancy in groups of 24 and 30 female mice after 
twice-weekly applications of 10% phenol for 72 and 52 weeks, respectively.
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From studies using albino mice, [175-179] no definitive conclusions 
concerning phenol as a carcinogen or promoting agent can be made. Phenol 
as a nonspecific irritant may promote development of tumors when applied 
repeatedly to the skin in large amounts.
Skin contact with either liquid or solid phenol has led to serious 
consequences in humans, and numerous reports indicate that such contact 
with phenol in even small amounts represents a serious hazard in the 
occupational environment. [79,82,86,96,111,112,202,204]
Controlled-inhalation and skin-absorption studies conducted by 
Piotrowski [97] on 8 human volunteers clearly showed that phenol absorbed 
by inhalation of vapor at concentrations at or below 20 mg/cu m (5.2 ppm) 
or by skin exposure at vapor concentrations at or below 25 mg/cu m (6.8 
ppm) was completely eliminated within 24 hours, and that there was no sign 
or symptom of any biologic disorder. In addition, Ohtsuji and Ikeda
[98] supported the above findings by showing that employees who received a 
combined inhalation and skin exposure to phenol vapor at concentrations up 
to 12.5 mg/cu m (3.3 ppm) readily detoxified the absorbed phenol during 
their shift. Excretion of conjugated phenol was still apparent in the 
urine prior to the next shift, but free urinary phenol concentrations 
remained essentially unchanged and at background levels. These 
investigators [98] further substantiated Piotrowski's findings [97] in that 
no ill effects were reported in any of the employees surveyed.
Cosgrove and Hubbard [171] demonstrated that the rabbit eye is com­
pletely destroyed by one drop of 87% phenol in glycerin. Corneas remained 
clear in test animals, when there was immediate irrigation with water. 
However, if irrigation of the eyes was delayed for 10 seconds or more after
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application, the cornea became opaque in 40% of the animals tested. By 
using more dilute solutions of phenol in glycerin (10-50%), a greater 
percentage of animals developed corneal opacities with delayed irrigation. 
Therefore, any phenol in the eyes should be regarded as a serious emergency 
requiring immediate irrigation with copious amounts of water. Eye 
protection, eyewash fountains, and deluge showers are mandatory.
Studies by Sandage [180] (see Table XII-13) clearly showed no ill 
effects in monkeys, rats, and mice exposed to phenol vapor at 5 ppm (19 
mg/cu m) for 8 hours/day, 5 days/week, for 90 days. Deichmann et al [174] 
exposed guinea pigs, rabbits, and rats to phenol vapor at 26-52 ppm (100- 
200 mg/cu m) for 7 hrs/day, 5 days/week (see Table XII-12). Twenty-nine 
such exposures killed 5 of 12 guinea pigs, and post mortem examination 
revealed necrosis of the myocardium, acute lobular pneumonia, and hepatic 
and renal vascular damage. Although none of 6 rabbits receiving 63 such 
exposures showed any signs of illness or discomfort, they showed similar 
but less severe changes at autopsy. None of 15 rats receiving 53 exposures 
exhibited any signs of illness or discomfort, and no pathologic changes 
were reported. [174]
Ingestion of relatively small amounts of phenol is immediately 
hazardous to human life (see Table XII-9). Ingestion of as little as 4.8 g 
of phenol has caused death within 10 minutes. [205] Ingestion of 48 ml of 
a 1-2% phenol solution (0.5 to 1.0 g of phenol) 3-4 times/day [56] produced 
a burning sensation in the throat, giddiness, cold and profuse 
perspiration, a weak pulse, and darkened urine. Although ingestion of 
either a single dose of 60 ml of a 2% phenol solution (1.2 g) [206] or 48 
ml of a 0.2% phenol solution (0.1 g) 3-4 times in a single day produced no
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immediate ill effects, [56] only small doses of a few grams were necessary 
to cause death in humans. [112,205] Therefore, it is recommended that 
appropriate work practices be used to minimize any phenol exposure by 
ingestion.
There are no data to suggest a substantial change in the current 
federal standard, and an environmental limit for phenol at 20 mg/cu m 
expressed as a TWA concentration for up to a 10-hour workday is 
recommended. Except for addition of a skin notation in 1961, the threshold 
limit value for phenol has not been changed since it was established at 5 
ppm in 1952. The body burden for exposure to phenol at 20 mg/cu m would 
have a maximum steady state value of about 50 mg throughout the shift. 
This amount of phenol is well within the physiologic range for 
detoxification or elimination. [167,173,182, 192]
Phenol is detectable by odor at a threshold of 0.05 ppm (see Table 
XII-1) which may be annoying to some people. Fuller [56] found that phenol 
in large amounts (1-2 g) could be tolerated for short durations several 
times a day but that the toxic threshold dose for phenol can be only a few 
grams. [78,205,206] To avoid irritation by phenol and to minimize exposure 
to large amounts, a ceiling limit of 60 mg phenol/cu m of air based on a 
15-minute sampling period has been added to the recommended standard.
Occupational exposure is defined as exposures to phenol at airborne 
concentrations in excess of one-half the recommended TWA environmental 
limit, and medical surveillance shall be made available to employees who 
are thus exposed. This provision is necessary to provide a basis for 
diagnosis, intervention, treatment, or rehabilitation in cases of potential 
phenol overexposure and to identify those individuals with preexisting
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conditions, such as skin, eye, kidney, liver, heart, or lung disorders, 
that might place them at increased risk from occupational exposure to 




Employees should be informed that "protective creams" do not afford 
adequate or acceptable skin protection from contact with phenol. [2]
Phenol tanks and pipelines should not be placed underground [321] as 
leakage from underground tanks or lines is more difficult to locate and to 
repair in the event of leakage. Surrounding earth can become sufficiently 
impregnated with phenol that it may present a hazardous exposure to 
employees digging to uncover and to repair the leak, and the contamination 
may extend beyond the leak to expose other individuals.
Food should neither be stored nor eaten in a workplace where phenol 
is stored or used. [2] Employees should be given warnings strongly
emphasizing the serious injury which may result from ingestion of even very 
small amounts of phenol. Employees should exercise great care that phenol 
from contaminated gloves, garments, or respirators not be transferred to 
the eyes, mouth, or skin. Protective clothing should be cleaned and 
decontaminated after each use.
Washing facilities, showers, and lockers should be provided in
conveniently located change rooms. Employees should be urged to practice 
good personal hygiene by washing and showering after each work shift. They 
should change work clothes each day. Work clothes should be laundered 
after each wearing.
Clean and hygienic lunchroom or lounge areas should be provided for
the use of employees, but such areas should be separate and protected from
exposure to or contamination by phenol. These areas or similarly provided
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areas should be used for smoking, drinking, or eating during work breaks.
Smoking must be prohibited in areas of possible phenol exposure to 
avoid unnecessary sources of ignition and possible increased risk from 
exposure to toxic products of combustion.
Swabbing the contaminated skin with a 2:1 mixture of polyethylene 
glycol 300 and industrial methylated spirits is effective for removal of 
phenol. [172,201,322,32 3] Recently, Pullin et al [324] used pigs to
compare the swabbing technique with deluge showers of water. They 
concluded that either swabbing or water shower, properly used, was equally 
effective. Since deluge showers containing anything but water are 
inappropriate, the recommended method of decontamination of the skin from 
an exposure to phenol is the use of a water deluge shower. Such showers 
should be available wherever large volumes of phenol are in use or whenever 
there is a significant risk of exposure to phenol.
In emergencies or in nonroutine operational situations where either 
engineering or administrative controls are not capable of maintaining the 
amount of exposure at or below the recommended TWA environmental limit, the 
wearing of approved respiratory protective devices (see Chap I, Sect 4) is 
essential. Because of the sensitivity of the eye to phenol, only full 
facepiece respiratory protective devices are recommended. [2]
Phenol spills and leaks must be cleaned up immediately and employees 
engaged in cleanup must wear adequate personal protective garments and 
respiratory equipment (Chapter I). Employees must avoid skin and eye 
contact with solids or liquids and also must avoid prolonged breathing of, 
or exposure to, phenol vapor. Often an adequate cleanup procedure consists 
of flushing spilled phenol to a drain with an abundant flow of water and
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subsequent drainage into an enclosed waste treatment or disposal system. 
Phenol wastes should not be flushed into a community sewer system unless it 
has been determined that such action will neither interfere with sewage
treatment nor result in contamination of water sources sufficient to 
violate applicable regulations and ordinances.
Phenol waste must be disposed of or treated in a manner which does 
not result in prohibited or undesirable contamination of water, air, or 
land. Phenol can be recovered from waste by adsorption on charcoal, 
solvent extraction, or steam stripping. [2] Phenol may be destroyed by 
either chemical or biologic oxidation processes. The latter processes 
usually involve impounding the waste liquor, in which case precautions are 
necessary to ensure that seepage does not contaminate ground water.
Phenol is capable of reaching flammable (explosive) vapor
concentrations. The lower explosive limit is 1.5% (by volume in air) which 
is the equilibrium concentration at 75 C (167 F). The closed-cup flash 
point is 79 C (174 F). [2] High concentrations of phenol in an employee’s 
breathing zone are not likely to occur in a workplace unless phenol is 
heated. Although inhalation of phenol may not be likely in a particular 
area where phenol is used, the danger of explosion should be considered,
and measures should be taken to maintain the concentrations of phenol vapor
and oxidizing agents below the explosive limit and to eliminate ignition 
sources, particularly in closed systems. Sprinkler systems, alcohol foam, 
carbon dioxide, and dry chemicals are effective extinguishers for fires 
involving phenol. [2]
Good work practices, personal hygiene, and proper training of 
employees are necessary for the control of occupational hazards associated
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with exposure to phenol. Employees must be thoroughly trained in all the 
procedures and equipment required in their employment and in the use of all 
appropriate emergency procedures and equipment.
Phenol destroys tissue, but it also has a local anesthetic action. 
Any contact with phenol may result in significant absorption without 
noticeable pain. The employer should require that each instance of phenol 
contact with the skin or eye be reported promptly and that appropriate 
first aid be administered. Review of reports should be carried out at 
regular intervals (not greater than 6 months) to identify processes, 
procedures, operations, equipment, job sites, or personnel showing repeated 
or unusual frequency of contact with phenol. Surveillance and careful 
attention to prevention of significant contact with solid or liquid phenol, 
and the elimination of processes involving prolonged or repeated exposure 
to phenol vapor should be significant factors in reducing occupational 
exposure and preventing injury. Tf proper work practices are ignored or 
carelessness is tolerated, serious injury is likely to occur in spite of 
protective equipment and systems. Skin contact is a major danger in 
working with phenol. The effective use of good work practices is entirely 
dependent on the knowledge and the cooperation of employees and employers.
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VII. OCCUPATIONAL RESEARCH PRIORITIES FOR PHENOL
(1) Chronic Effects
The effects of chronic exposure to phenol at low concentrations 
require investigation. With few exceptions, human experience with phenol 
by skin contact, inhalation, or ingestion has been by exposures to 
overwhelming amounts (see Tables XII-7,8, and 9). Epidemiologic 
investigations of occupational groups are lacking, and information on 
concentrations of phenol in air and any associated clinical findings would 
be useful. Chronic exposure of animals to phenol at concentrations in the 
range of the recommended environmental limit also would be appropriate.
(2) Mechanism of Action and Metabolism
There is uncertainty regarding the normal values for phenol in blood 
and urine for humans, and research should be conducted on biologic 
monitoring and determination of normal values. Phenol is a normal 
metabolite and may be derived from a variety of endogenous sources 
including proteins and medications. Within physiologic limits, phenol does 
not appear to produce toxic effects. In excess of these limits, toxic 
effects are produced in several organs, and research on the mechanism of 
action might allow development of preventive measures and a specific 
therapeutic regimen for phenol intoxication.
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(3) Monitoring Techniques
Analytical and sampling methods for determination of phenol in 
workplace air require refinement to provide more adequate personal 
monitoring techniques. Direct reading devices and continuous monitors 
suitable for breathing zone determinations would be useful.
(4) Carcinogenic Studies
Well-controlled experiments using several animal species should be 
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IX. APPENDIX I
SAMPLING OF PHENOL IN AIR
Sampling
Air samples are collected in the breathing zone of employees by 
drawing air through an all-glass midget impinger containing 15 ml of 0.1 N 
sodium hydroxide solution. If the work operation allows the impinger to be 
maintained in a vertical position, it may be possible to attach the 
impinger to the employee's clothing. A personal sampling pump may also be 
attached to the employee's clothing. However, a significant amount of 
bending from the waist may make impinger sampling impractical. Samples 
should be collected as close to the breathing zone as possible. Air being 
sampled should not pass through any other tubing or equipment before 
entering the impinger. The sampling pump is protected from splashover or 
solvent condensation by a 5-cm long by 6-mm ID glass tube loosely packed 
with a plug of glass wool and inserted between the exit arm of the impinger 
and the pump. Sampling is performed for at least 15 minutes at a rate of 1 
liter/minute. The flow rate, with the impinger on line, should be checked 
before and after the sample is taken.
After sampling, the impinger stem can be removed and cleaned, first 
tapping the stem gently against the inside wall of the sample flask to re­
cover as much of the sampling solution as possible, then washing with a 
small amount (1-2 ml) of distilled water and adding the wash to the sample 
flask. The flask is then sealed tightly with a hard, nonreactive stopper, 
preferably Teflon, but never with rubber. Shipment of sample flasks should 
be with the stems in, the opening of the stem should be sealed with
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Parafilm or equivalent nonrubber covers, and the standard taper joints 
should be sealed usually by means of plastic tape. Precautions should be 
taken to minimize spillage or loss by evaporation at all times. 
Refrigerate samples if analyses cannot be performed within a day in order 
to minimize chemical reactions which might otherwise occur. Whenever 
possible, hand delivery of samples is recommended, or special shipping 
cases should be used. A blank impinger should be handled in exactly the 
same manner as the other samples (fill, seal, and transport) except that no 
air is sampled through this impinger.
Calibration
Since the accuracy of an analysis is often limited by the accuracy of 
the volume of air which is measured, accurate calibration of a sampling 
device and flowmeters is essential. Frequency of calibration depends on 
the use, care, and handling to which the sampling system is subjected. 
Pumps should be calibrated if they have been subjected to abuse or if they 
have just been repaired or received from a manufacturer. When sampling 
highly polluted or dusty environments, frequent cleaning and calibration 
may be necessary because the orifices of flow meters and other equipment 
may become contaminated.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. The accuracy of calibration depends highly on the 
type of instrument used as a reference, and choice of calibration procedure 
will depend largely upon where the calibration is to be performed. For 
laboratory testing, a 1-liter buret or a wet-test meter is recommended,
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although other standard calibrating instruments, such as spirometer, 
Marriot bottle, or dry-gas meter, can be used. The actual set-up should be
similar for all calibration systems used. The calibration instrument
should be connected first in a series to the sampling train which will be 
followed by the sampler pump. In this way, the calibration instrument will 
be at atmospheric pressure. If a personal sampling pump is used, each pump 
must be calibrated separately. If a buret is used for calibration, it 
should be set up so that the flow is toward the narrow end of the unit.
Care in the assembly of the calibration set-up ensures that seals at 
the joints are airtight and that the length of connecting tubing is at a 
minimum. Calibration should be performed at essentially the same 
conditions of pressure and temperature as those under which it is
anticipated that the sampling will occur. A calibrated pump rotameter
should be used to establish flow rate in the field.
Apparatus
The sampling unit for the impinger collection method consists of the 
following components:
(a) A standard glass midget impinger containing the collection 
medium.







ANALYTICAL METHOD FOR PHENOL IN AIR
Principle of the Method
A known volume of air is drawn through a midget impinger containing 
15 ml of 0.1 N sodium hydroxide as the collection medium. The resulting 
solution is acidified with sulfuric acid. An aliquot of the collected 
sample is injected into a gas chromatograph. The area of the resulting 
trace is determined and compared with similar areas obtained for standards. 
Use of an internal standard is highly recommended.
Range and Sensitivity
This method [313] was validated over the range of 9.46-37.8 mg/cu m 
at an atmospheric temperature of 22 C and atmospheric pressure of 760 mmHg, 
using a 100-liter sample. With a 100-liter sample, the probable useful 
range of this method is 5-60 mg/cu m at a detector sensitivity that gives 
nearly full deflection on the strip chart recorder for a 6-mg sample.
Interference
Any compound which has the same retention time and detector response 
as phenol under the GC operating conditions described in this method may 
interfere in the analysis. Retention time data on a single column cannot 
be considered proof of chemical identity. If there is possible 
interference, separation conditions (column packing, temperature, flow 
rate, etc) must be changed to circumvent the problem.
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Precision and Accuracy
The coefficient of variation for the total analytical and sampling 
method in the range of 9.46-37.8 mg/cu m was 0.068. This value corresponds 
to a 1.3 mg/cu m standard deviation at 19 mg/cu m. A collection efficiency 
of 1.0 0 + 0 . 0 1  was determined for the collecting medium.
In general, the analytical results obtained for phenol at 
concentrations of 5 ppm (19 mg/cu m) using the recommended overall sampling 
and analytical method averaged 2.6% less than the "true" concentrations for 
a limited number of laboratory experiments. Since the coefficient of 
variation is greater than 0.026, any difference between the "found" and 
"true" concentrations may not represent a bias in the sampling and 
analytical method, but rather a random variation from the experimentally 
prepared "true" concentration. Therefore, it should not be necessary to 
apply a recovery correction to the final result.
Advantages and Disadvantages of the Method
Samples collected in impingers are analyzed by means of a quick, 
instrumental method. However, under certain work conditions, impingers 
attached to an employee's clothing and containing sodium hydroxide may not 
be suitable for breathing zone samples. The GC instrumental method is 




(a) Gas chromatograph (GC) equipped with a flame ionization 
detector (FID)
(b) Column (4-ft long x 1/4-in OD stainless steel) packed with 
35/60 mesh Tenax. [325]
(c) An electronic integrator or some other suitable means for 
measuring peak areas.
(d) Microl syringes - 10 ¡ i 1 and other convenient sizes for making 
standards and injecting samples into the GC.
(e) Volumetric flasks - convenient sizes for making solutions.
(f) Pipets - 15 ml and other convenient sizes.
Reagents
(a) Distilled water.
(b) Phenol - reagent grade.
(c) Sulfuric acid - reagent grade.
(d) Sodium hydroxide - 0.1 N solution.
Dissolve 4.0 g of sodium hydroxide in distilled water (carbon dioxide 
free) and dilute to a final volume of 1 liter.
(e) Purified nitrogen.
(f) Purified hydrogen.
(g) Filtered compressed air.
(h) Standard solutions.
Six standard solutions at each of the three concentrations (0.5x, lx, 
and 2x the recommended TWA concentration limit) are prepared by adding 1 
mg, 2 mg, or 4 mg of phenol to 15-ml aliquots of 0.1 N sodium hydroxide
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contained in 25-ml volumetric flasks. The amounts introduced are 
equivalent to that present in a 100-liter air sample at multiples of the 
recommended limit. The solutions are acidified with 0.1 ml of concentrated 
sulfuric acid and made up to volume with distilled water. The solution 
should be checked to confirm that the pH is less than 4. A reagent blank
is prepared in the same manner, except that no phenol is added. The
standards and blank are analyzed in the manner indicated below.
Procedure
(a) Cleaning of equipment
All glassware used for the laboratory analysis should be washed with 
detergent and thoroughly rinsed with tap water and distilled water.
(b) Analysis of samples
Transfer the solution to a 25-ml volumetric flask. Rinse the 
impinger twice with 1 ml of distilled water and add the rinses to the
flask. Add 0.1 ml of concentrated sulfuric acid to the flask and mix.
Check to ensure that the pH is less than 4. Dilute to mark with distilled 
water and mix. Typical operating conditions for the gas chromatograph are:
(1) 50 ml/min (60 psig) nitrogen carrier gas flow.
(2) 65 ml/min (24 psig) hydrogen gas flow to detector.
(3) 500 ml/min (50 psig) air flow to detector.
(4) 215 C injector temperature.
(5) 225 C manifold temperature (detector).
(6) 200 C column temperature.
The first step in the analysis is injection of the sample into the 
gas chromatograph. To eliminate difficulties arising from blowback or 
distillation within the syringe needle, employ the solvent flush injection
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technique. The 1 0 - f i l  syringe is first flushed with solvent several times 
to wet the barrel and plunger. To increase the accuracy and reproduci­
bility of the injected sample volume, 3 £*1 of solvent are drawn into the 
syringe. The needle is removed from the solvent, and the plunger is pulled 
back about 0.2 f i l to separate the solvent flush from the sample with a 
pocket of air to be used as a marker. The needle is then immersed in the 
sample, and a 5-/il aliquot is withdrawn taking into consideration the 
volume of the needle, since the sample in the needle will be completely 
injected. After the needle is removed from the sample and prior to 
injection, the plunger is pulled back 1.2 f i l to minimize evaporation of the 
sample from the tip of the needle. Note that the sample occupies 4.9-5.0 
l i l  in the barrel of the syringe. Duplicate injections of each sample and 
standard should be made. No more than a 3% difference in area is to be 
expected. An automatic sample injector can be used if it is shown to give 
reproducibility at least as good as the solvent flush method.
The area of the sample peak is measured by an electronic integrator 
or some other suitable means of area measurement, and preliminary results 
are read from a standard curve prepared as discussed below.
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Calibration and Standards
It is convenient to express concentration of standards in terms of
mg/15 ml of collection medium because samples are collected in this amount 
of collection medium. Solutions varying in concentration over the range of 
interest are prepared and analyzed under the same GC conditions and during 
the same time period as the unknown samples. Curves are established by 
plotting concentration in mg/15 ml versus peak area. Note that since no 
internal standard is used in the method, standard solutions must be
analyzed at the same time that the sample analysis is done. This will 
minimize the effect of known day-to-day variations and variations during 
the same day of the FID response.
Calculations
Read the weight in mg corresponding to each peak area from the stan­
dard curve. No volume corrections are needed because the standard curve is 
based on mg/15 ml collection medium and the volume of sample injected is 
identical to the volume of the standards injected. Corrections for the 
blank must be made for each sample.
corrected mg = mg sample - mg blank
where:
mg sample = mg found in sample impinger 
mg blank = mg found in blank impinger
The concentrations of phenol in the air sample can be expressed in mg/cu m.
mg/cu m = corrected mg x 1000 (liter/cu m) 
air volume sampled (liter)
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Another method of expressing concentration is ppm.
where :
ppm = mg/cu m x 24.45 x 760 x T + 273
MW P 298
P = pressure (mmHg) of air sampled 
T = temperature (degrees C) of air sampled 
24.45 = molar volume (liter/mole) at 25 C and 760 mmHg 
MW = molecular weight (g/mole) of phenol = 94.11 
760 = standard pressure (mmHg)
298 = standard temperature (degrees K)
127
XI . APPENDIX III 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor's name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, ie, "100 ppm LC50-oral-rat," "25 mg/cu m 
LD50-skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.93," or, if not available, from other sources of publications such as 
the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity,
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or similar descriptive data may be used to indicate flammability, 
reactivity, or similar properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury (mm 
Hg); vapor density of gas or vapor (air = 1); solubility in water, in
parts/hundred parts of water by weight; specific gravity (water = 1);
percent volatiles (indicate if by weight or volume) at 70 degrees
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is 
also useful for design and deployment of adequate fire and spill
containment equipment. The appearance and odor may facilitate
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the
product, including flash point and autoignition temperature in degrees
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50, if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect 
the potential hazard from absorption by the route in question. Comments 
should indicate the severity of the effect and the basis for the statement, 
if possible. The basis might be animal studies, analogy with similar pro­
ducts, or human experiences. Comments such as "yes" or "possible" are not 
helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effect likely; 
prolonged or repeated contact, mild irritation and possibly 
some blisteringi
Eye Contact— some pain and mild transient irritation; no 
corneal scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It shall also include dangerous products produced 
by aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to 
cleanup detail. Specific neutralizing chemicals or procedures should be 
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill," or "incineration." Warnings such ^s "comply with 
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Mines 
approval class, ie, "Supplied air," "Organic vapor canister," "Suitable for 
dusts not more toxic than lead," etc. Protective equipment must be 
specified as to type and materials of construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on
any aspect of safety or health not covered in other sections should be
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling or storage.
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
potentially exposed to the hazardous material. The MSDS can be used as a
training aid and basis for discussion during safety meetings and training 
of new employees. It should assist management by directing attention to 
the need for specific control engineering, work practices, and protective 
measures to ensure safe handling and use of the material. It will aid the 
safety and health staff in planning a safe and healthful work environment 
and suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M A N U F A C T U R E R  S NAME
R E G U L A R  TELEPHONE NO. 





m a t e r i a l  o r  c o m p o n e n t % H A Z A R D  D A T A
III PHYSICAL DATA
S O IL IN G  POINT,  760 MW HG M E L T IN G  POINT
SPECIFIC G R A V IT Y  (H20  = 1l VAPOR PRESSURE
VA POR DE NS IT Y  (A IR -1 ) S O L U B IL IT Y  IN H20 ,  % BY WT
% V O L A T IL E S  BY VOL EV A P O R A T IO N  RATE (BUTYL ACETATE ; 1 >
APPEARANCE A N D  ODOR
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IV FIRE AND EXPLOSION DATA
FLASH POINT 
(TEST METHOD)
A U T O IG N IT IO N
TE M P ERA TUR E
F L A M M A B L E  L IM ITS  IN A IR ,  % BY VOL. LOWER UPPER





U N U S U AL  FIRE 
A N D  EXPLOSION 
H A Z A R D
V HEALTH HAZARD INFORMATION
H E A L T H  H A Z A R D  D A T A
ROUTES OF EXPOSURE 





EFFECTS OF OVEREXPOSURE 
ACUTE OVEREXPOSURE
CHRONIC OVEREXPOSURE
EMERGENCY AN D  FIRST A ID  PROCEDURES 







CONDITIONS CONTRIBUTING TO INSTABILITY
INCOMPA1 iB ILITY
HAZARDOUS DECOMPOSITION PRODUCTS
CONDITIONS CONTRIBUTING TO HAZARDOUS POLYMERIZATION
VII SPILL OR LEAK PROCEDURES
STEPS TO BE TAKEN IF M ATER IAL IS RELEASED OR SPILLED 
NEUTRALIZING CHEMICALS
WASTE DISPOSAL METHOD
VIII SPECIAL PROTECTION INFORMATION
VENTILATION REQUIREMENTS
SPECIFIC PERSONAL PROTECTIVE EQUIPMENT 
RESPIRATORY (SPECIFY IN DETAILI
EYE
GLOVES v











XII. TABLES AND FIGURES 
TABLE XII-1 











Solubility: (X is mole fraction.)
Phenol in water:
-log x = 0.375 log(66-T) + 1 . 1 5  
Water in phenol:
-log x = -0.62 log(66-T) + 0.99 

















3.24 (air = 1)
Also soluble in ether, 
alcohol, acetic acid, 
glycerol, liquid sulfur 
dioxide, and benzene
Colorless to light pink 
solid






















Coal Tar 50 2.0
TOTAL 2460 100.0
From Chemical Profiles [5]
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TABLE XII-3
1972 USE PATTERN OF PHENOL








From Chemical Profiles [5]
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TABLE XII-4 



































intrathecal injections for the 38-48
relief of flexor spasms
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TABLE XII-5
SELECTED OCCUPATIONAL GROUPS POTENTIALLY EXPOSED TO PHENOL
Occupational Groups References
Antiseptic workers 16,17,22,23,25
Aromatic compound synthesizers 8,17
Asbestos makers 11,14
Battery makers, dry 321
Chemical makers 9,14,17














Lubricating oil processors 13,326
Metal cleaners 21
Motor oil workers 93
Paintmakers 8,11,326









SELECTED OCCUPATIONAL GROUPS POTENTIALLY EXPOSED TO PHENOL
Occupational Groups References
Photographic material workers 14,326








Stillmen, carbolic acid 326
Surgical dressing makers 326
Textile printers 326
Tanning substance makers 9,11,14,17,25
Varnish and lacquer makers 8,326
Weed killer users 326
Wood preserver users 8,11,14,326
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TABLE XII-6
















reduced body temperature 
elevated body temperature 
dilated pupils 
constricted pupils 
absence of comeal reflexes 
difficulty in swallowing 
profuse perspiration 
rales



















































ADVERSE EFFECTS PRODUCED BY EXPOSURE TO PHENOL
Effects References
Via Skin Absorption (continued)
albuminura 66
hematuria 202





damage to blood-forming organs 62,331
increased irritability 329




local tissue irritation 56,63,110










reduced body temperature 110
difficulty in swallowing 56
profuse perspiration 56,65
























absence of corneal reflexes
































































ADVERSE EFFECTS PRODUCED BY EXPOSURE TO PHENOL
Effects References
Via Contact with Open Wounds:
death 55,59,60,328
local tissue irritation 55,106,339


















loss of appetite 106
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TABLE XII-6 (CONTINUED)
ADVERSE EFFECTS PRODUCED BY EXPOSURE TO PHENOL
Effects References
Via Contact with Mucous Membranes: 
Uterus-
death 342
local tissue irritation 342,343
collapse 342
local tissue necrosis 342,343
irregular pulse 342
darkened urine 343
absence of comeal reflexes 342
hematuria 343




local tissue irritation 344













HUMAN RESPONSES TO PHENOL AT VARIOUS 












? Marked irritation of
the nose, throat, and eyes.
HCHO may be primary cause.
95
1.5-5.2 6-20 8 hrs with 
2 30-min 
breaks
8 No ill effects. 60-88% of 97 
phenol absorbed by lungs. Rise 
in urinary excretion of phenol 
during exposure with a return to 
preexposure levels within 24 hrs











8 hrs/day 29 "Poisoning" 88
0.047 0.18 Minutes 4 Odor threshold average 135
0.006-0.048 0.022-0.184 I f 14 Odor threshold range 17
0.006-0.024 0.022-0.094 I f 19 f ! 136
0.006 0.024 15 sec 4 Conditioned electrocortical 
reflex in all
17
0.004 0.0155 5 min 3 Increased sensitivity to 





HUMAN RESPONSES TO SKIN CONTACT WITH PHENOL
Concen­
tration Contact Most Severe

















Cresols & Less than 
water 5 min
Water 10 min


























Spill on cheeks & 1
scalp
Fxploslon 1
Spill on hip, thigh, 1
scrotum
Closed dressings on 11
open wounds
Broken flask in lab 1
Spill on scalp, face, 1 
neck, shoulders, and 
back
Applied daily on ec- 1
zematous back
Self-exposure—  1











1 death, 8 pas gang­
rene, 11 tissue necrosis
Bums on hands, later 













4-5 liter spill on 1
upper body
Spill on lower body, 1
irrigation with warm water 
for 30 min, followed by 
swabbing with ethanol for 
10 min, followed by repe­
tition of procedure
Covered with itrrper- 1 Coma 
vlous dressing
Covered dressing
Some local Irritation 
Edema, anesthesia 
Burning sensation 
Increasing pain & edema 
Increased sensitivity to touch 
Desquamation 
Crusting & sloughing 
Coma "86
82





Closed dressing on cut 1 Gangrene




























5 Water )4.5 hr Phenol soaked comprcsa 
on thigh abscess
1 Coma 112
5 70 mln Phenol soaked compress 
on broken skin
1 u 112
<5 " 16-20 hra Closed soaked dressing 
on finger
3 Cangreoe 340
4.75 Camphor 1- 7 days Painted on hand> 
arms, feet, & lower 
abdomen
3 local tissue necrosis 90
4 Water + 
boric acid
16-20 hra Applied twice on head, 
arms» & thighs
1 Cyanotic, rapid pulse, 
kidney damage
3«S
U Water 7.5 hra Rubbed on chest, ab­
domen , & back
1 Coma 66
2 . 5 " 2 hra Legs wrapped In soaked 
tovela
1 ti 341
2.5 ti 3 mln Stale bread poultice 
over entire body
1 111
2 it 2.5 daya Moist dressing over 











Closed bandage on in- 
fant umbilicus 
Rubbed on scalp, anna, 










5.5 hra No inhalation dose, 
naked





1» tt No inhalation dose* 





" ** (« B ti 97
1.2-1.4
ppm
n ii «i 8 ti 97
151
TABLE XII-9










100 120 128 1 45 min Death 69
100 60 64 1 Shortly » 71
100 60 64 1 1.5 hra J’ 70
88 60 56 1 45 mln Collapse 75
90 40 39 1 hr Death 109
100 30 32 1 Min M 71
100 30 32 1 50 min Coma 68
100 30 32 1 15 min » 75
82 30 26 1 3 min Death 327
100 15 16 1 1.5 hr " 75
100 10-20 11-21 1 25 min t? 76









Several —— Burning sensation 
followed by giddiness, 
cold, profuse perspira­
tion» weak pulse, green 
tint to urine
56









Several -- h 56
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TABLE XII-10











None ---- ---- None or 0.0-0.*8 traces
Mllion's reagent 139
» None 0.07-0.9 " 140
•i — . 0.02 _ p-Nitroanlline 141
M __ 0.0-0.04 0.155 Million's reagent 142
” — — 0.05-0 .8 0.1-0.15 p-Nitroaniline 143144




II 1.36-1 .67 0.06-0.3 p-Nitroaniline 145
ft 1-2 0-0.2 n 146
II







































0.4 0.9-1.73 it 137
153
TABLE XII-11
















M --- ---- --- 1.0 -27.0 (total phenol)
Gibbs reagent 152
” ---- ---- ---- 9(total phenol)
? 153
" ---- --- ---- 2-18 (total phenol)
GLC 154
---- — ---- 7.8(total phenol)
Gibbs reagent 155









---- ---- ---- 3-28 (total phenol)
Gravimetric as 















---- ---- ---- 8.3-81.5 (total phenol)
Gibb’s reagent 128
• I

























25 mg/g 90 mg/g 
creatinine creatinine
Gibb's reagent 98
" •« Postshift, 
6th day





25 mg/g 35 mg/g 
creatinine creatinine
" 98
»» " PostBhift* 2 





ANIMAL RESPONSES FOLLOWING ACUTE PHENOL EXPOSURES
loge«•f



















10 hra 4 groups of 2 
























5 groups, of 
I to 3 each 
group
1 group of 10 










1 death at highest 
dose, chronic con­




tory rate ac inter­
mediate doses. No 









1 death with repeated 164 
dally Injections at 
intermediate dose; 
Inappetente and 
diarrhea at high doses 





Death of 10 at hl?h 166 
dose, in 1 to 6 days;
2 deaths at low dose 
la 2 - 3 days
Neuroouscular 
Irritability, convul- 
alons, cona, all sur­
vived. Frequent 
lntravascular hemolyst 








paralysis at doses of 
3(10 or below, death 
at each of 3 
higher doses
1 death at doses of 
400 and 300; trenor, 
convulsions, and 
paralysis for 2 
animals at a dose of 
300, and for 1 anlnal 




















Clycttln Kinut«s to 1
1600-6400 Vatsr (201 «ml«















Canphor-liijuià ? à*3r* 
petrolstuo
Put« liquid to 
102 v«e«r 


















(*•752 solo) Camphor-ltquiô **3 day* 









of the «y« ln minutes. 
Corneal opacities In 
402 of snlaals if 
vâter irrigation 
delayed 10 seconds or 
•or«; snd no effect 
if v*ter Irrigation 
performed lss&edlateiy












302 died on exposure 165 
to pure liquid vlth 
2 deaths Increasing 
Inversely to 2 of phenol 
la vacer resulting In 
1002 deaths vlth 
Application of a 102 
emulsion
1 death and tlssua 169
necrosis at highest 
dose, severe ereoor 
at Intermediate doses, 
and ml Id hyperemia and 





All 20 «C high dose 
died, 5 out 10 died 
at a dose of ¿20, and 
¡remaining ** survived 
the lev dose 




















Entry ■*A« Mad 1m T1m ■ lupo«» taf«rane«a
U t Skin (2.75X
•elm)
1 tir /day, 
3 days





Vacar ■ 40 • 169




■ • S 169
■ ■ 0.73X
•ola)
Fatrolatua m 5 m 169





Daath la about 50X 163
m m 1300
(10Z aoln)




Vatar ■ 45 m 163
157
TABLE X U - 1 3
d o s e - r e s p o n s e  r e l a t i o n s h i p s  f o l l o w i n g i n h a l a t i o n o f  p h e n o l by a n i m a l s
Species
Concentration 
ppm mg/cu to Time N Response References
Guinea
pi*
26-52 100-200 7 hrs/day, 
5 days/vk
12 29 exposures, 5 deaths
Post mortem rcvoal^d extensive ■necrosis
of thfc myocardium» acute lobular pneumonia,
and damage to vascular, hepatic, and renal
tissue.
174
Monkey 5 19 8 hrs/day, 
5 days/wk, 
90 days
10 General health, hematology, urinalysis, 
blood chemistry, Vidney function, stress 
tests, and post mortem pathology and his­
tology ßane as controls. Weight gain over 
controls (p < 0.05)
180
Mouse 5 19 100 General health, hematology, urinalysis, 
blood chemistry, kidney function, body 
weight and post-mortem pathology and his­
tology same as controls. Stress tests re- 
vealed increased endurance over controls 
(p < 0.05)
C
No signs of illness or discomfort. Post 
mortem revealed lobular pneumonia, chronic 
purulent bronchitis, degenerative changes 
in pulmonary blood vessels, myocardial de­
generation, and Indications of liver & kid­
ney damage
180









15 No signs of illness. Post-mortem shoved 
no pathologic or histoloRlc change»
174
Rat 5 19 8 hrs/day, 50 General health, hematology, urinalysis, cy­
tology same as controls, Weight gain over 
controls (p < 0.05)
180
House 5 19 100 General health, hematology, urinalysis, 
blood chemistry, kidney function, body 
weight and post-mortem pathology and his­
tology same as controls. Stress tests re­
vealed increased endurance over controls 
(p < 0.05)
180





6 No signs of illness or discomfort. Post 
mortem revealed lobular pneumonia, chronic 
purulent bronchitis, degenerative changes 
blood chemistry, kidney function, stress 
tests, and post mortem pathology and his­
tology same as controls. Weight gain over 
controls (p < 0.05)
174
1,4 5.2 24 hrs/day, 
61 days
15 Sluggish, weight changes (p less than 
0.01), altered motor chronaxy (p less than 
0.01), increased blood cholinesteras« 
activity (p < 0.01)
17
•t 0,03 0.11 24 hrs/day, 
61 days
15 Healthy, no weight changes, motor chroo- 
axy changes (p < 0.03), increased 
Cholinesterase activity (p < 0,01)
17
»1 0,003 0.011 15 Healthy, no weight change, unaltered





ANIMAL RESPONSES FOLLOWING ORAL ADMINISTRATION OF PHENOL IN WATER
Species Dose (ppm) Medium Obsirvatlon Time N Response
Rat 0-4,000
3,000-5,000
Drinking water 5 generations ? No change
No significant chang«
7,000 2 generations " Stunted growth In voung
"
6,000 ii » Mothers did not routinely 
care for young
" 10,000 i* 1 year Offspring died at birth
12,000 ii No reproduction, premature 





















20 None 0.1 ml 52 phenol 
in acetone, 1/vk, 
at 2 sites in 
rotation* 32 wks
0 0 0 18 at 45 wk 45
20 0.2 ml 0.152 DMBA 











20 0.025 ml 201 phenol 




13 at 37 vk 45
20 None 0.075 ml 202 phenol ? ? 7
(1)**






PROMOTING ACTION OF PHENOL ON DEVELOPMENT OF SKIN TUMORS IN VARIOUS
STRAINS OF ALBINO MICE










Sutter M 23 75 pg 
(0.025 ml of a 
0.32 DMBA in 
benzene
None 21/23 15 5 42
F 23 2.5 mg, 2/wk 
(0.025 ml of 102 
phenol in benzene)
22/23 95 73






ii 19 75 pg 
(0.025 ml of a 
0.3% DMBA in 
benzene)
None
(0.025 ml benzene 
2/wk)
0 20
•i ? 1.25 mg USP 
phenol, 2/wk 
(0.025 ml, 52 phenol 
in benzene)
37 20
? it 1.25 mg USP 
phenol, 2/wk 
(0.025 ml, 52 phenol 
in benzene)
52 20
Holtzman H 30 ti None






II 30 it 1.25 mg, 1/wk 
(0.025 ml of 






M 30 75 pg 2.5 mg. 1/wk 
(0.025 ml of 0.39 (0.025 ml of 






22 0.025 ml of 
0.52 croton 
oil in benzene
21/22 4 • 36
M n 30 None 1.25 mg, 1/wk 
(0.025 ml of 
52 phenol in 
benzene)
30/30 3 36
(0.025 ml of 102 
phenol in benzene)
- - - 52
n 30 0.025 ml of 
0.52 croton 
oil in benzene
30/30 20 — 36
CAF1 •t 20 75 pg
(0.025 ml of a 
0.32 DMBA in 
benzene)
2.5 mg, 2/wk 
(0.025 ml of 102 
phenol in benzene)
60 21 52
" ti 20 Nona « - 0 0 52
CH3 ti 20 75 pg 
(0.025 ml of a 
0.32 DMBA In 
benzene)
ii 43 29 52
H i* 20 Nona n - 0 0 52
*pa~papilloma; **ca~--carcinoma 
Fron reference 176 161
TABLE XII-17
PROMOTING ACTION OF PHENOL ON DEVELOPMENT OF SKIN TUMORS IN 
















<0.015 ml of 0.3Z 
0KBA la acetone)
5 ■*
<0.025 »1 of 20Z 
phenol In acetone)
21/24 58 5 - - 12
• Wooe
(0*025 ml benzene)
12/12 0 0 0 U
m 5 as 
(0.025 al of 20Z 
phenol In benzene)
22/27 64 0 1.30 12
Boo* Kone
(0*025 al of benzene)
27/32 11 0 0.13 24
1.25 ag 
<0.025 al of 5X 
phenol In benzene)
27/33 74 4 1.67 24
■ 2.5 a(E 
(0.025 al of 10Z 
phenol in benzene)
10/33 100 26 3.94 40
• 3 ag 
(0.025 al of 20Z 
phenol in benzene)
15/33 100 93 3.70 39
n  n
(0.025 nl of 0.31 
DM3A In acetone)
1.25 as 
(0.025 al of 52 
phenol in benzene)
25/33 36 70 1.16 36
u
75 PS 
(0.025 >1 of 0.3Z 
DKBA la acetone)
2.5 ag
(0.025 al of 10Z 
phenol in benzene)
Sag












Root 5 ag 
(0.025 al of 20Z 
phenol in dloxane)
16/30 63 0 0.94 12
m 2.5 ag 
(0.025 al of 10Z 
phenol In benzene)
24/30 33 29 0.62 28
73 Pg
(0.025 ml o£ 0.31 
DMBA In acetone)
2.5 ag 
(0.025 al of 10Z 
phenol in acetone)
19/20 32 0 0.63 16
• Hone
(0.025 al of acetone)
18/20 0 0 0 16
* 2.5 ag 
(0.025 al of 10Z 
phenol in benzene)
16/20 88 0 2.62 12
« lone
(0.025 al benzene)
18/20 0 0 0 12
M m 18/20 0 0 0 20
m 1.25 ag 
(0.025 al of 5Z 
phenol in benzene)
13/19 31 8 0.46 20
■ 2.5 ag 
(0.025 al of 10Z 
phenol In benzene)
12/20 83 8 2.08 20
0.J5 „g 
(0.025 ml of 0.11 
DM&A tn tcetoo«)
Hone
(0.025 al of 30Z 
ethanol In acetone)
20/20 0 0 0 U
■ 0.025 al of 9.42 
(la) In 30Z 
ethanol in acetone
19/20 16 0 0.26 14
^ “ p a p illo m a ;  c * —carc in o m a
Fro* reference 176
TABLE XII-18








30 75 //g DMBA 
In acetone
None 10 7 17 15 mo 177




28 102 phenol 
In acetone 
2/vk
7 3 16 ti 177





33 10 17 177
30 10% phenol 
In acetone 
2/vk
87 70 4 1« 177
30 ii 10% phenol 
In acetone 
3/vk
80 47 3 « 177.
40 5 /ig Bap, 
0.005* in 
acetone, 3/vk
None 70 68 2 ii 177
28 II 5% phenol 
In acetpne 
2/vk
83 77 0 12 mo 177
28 II 10% phenol 
In acetone
2/vk
80 70 0 •« 177
20 150 fig DMBA 
In 0.1 ml acetone
None 2 1 52 178
20 3 mg phenol In 





20 5 jig BaP 
In 0.1 ml acetone 
3/vk, 460 days
3 mg phenol In 
0.1 ml acetone, 
3/vk, 460 days
3 1 179





EXISTING STANDARDS FOR PHENOL
Country
Standard 
mg/cu m ppm Type References
USA 1) Federal standard 19 5 TWA (skin) FR 39 (125) 1974
2) ACGIH recommendation 19 5 TWA (skin) 129
Bulgaria 5 — Ceiling 349
Czechoslovakia 20 5 n 320
f r 40 10 Peak 320
Federal Republic Germany 19 — Ceiling 349
Finland 19 5 t f 349
German Democratic Republic 19 — f l 349
Hungary 5 — rr 349
Poland 5 — 1! 349
Rumania 5 — I t 349
USSR 5 — I t 349
Yugoslavia 19 5 I f 349
USA -  Florida — 5 I t 349
- Mississippi — 5 1! 349
-  Pennsylvania — 5 M 349
-  South Carolina — 5 I I 349
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VALUES PRESENTED BY CZECHOSLOVAK COMMITTEE OF MAC
TABLE XII-20
Author Year mg/cu m Basis
Lazareff 1959 4 Smell
Smyth 1956 19 Suggestion for MAC
Bardodej 1960 20-30 Distinct smell; no 
damage was observed
Patty 1949 29 Smell
Deichmann 1944 100-200 Lung damage in guinea 
pigs after 20 days, in 
rabbits after 63 days; no 
damage noted in rats.
From Documentation of MAC in Czechoslovakia [320]
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FATE OF PHENOL IN A RABBIT GIVEN A SUBLETHAL ORAL DOSE 
ADMINISTERED DURING 24-HOUR PERIOD
FIGURE XII-1
Oxidized in body 
to CC> 2 and water 




FATE OF PHENOL ADMINISTERED 

























From Deichmann and Keplinger [196]
166
FATE OF PHENOL IN A RABBIT GIVEN A LETHAL ORAL DOSE 
ADMINISTERED DURING 5-HOUR PERIOD
FIGURE XII-2
FATE OF PHENOL ADMINISTERED 
During 5 -hour Period 
_________ (0 3 mg/Kg)_________
47% 3% 50%. Trace Trac
Oxidized in body 
to CO 2  and water 

















From Deichmann and Keplinger [196]
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